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Abstract
Calcium and apatite granulations are demonstrated here to form in both human and fetal bovine serum in response to the
simple addition of either calcium or phosphate, or a combination of both. These granulations are shown to represent
precipitating complexes of protein and hydroxyapatite (HAP) that display marked pleomorphism, appearing as round,
laminated particles, spindles, and films. These same complexes can be found in normal untreated serum, albeit at much
lower amounts, and appear to result from the progressive binding of serum proteins with apatite until reaching saturation,
upon which the mineralo-protein complexes precipitate. Chemically and morphologically, these complexes are virtually
identical to the so-called nanobacteria (NB) implicated in numerous diseases and considered unusual for their small size,
pleomorphism, and the presence of HAP. Like NB, serum granulations can seed particles upon transfer to serum-free
medium, and their main protein constituents include albumin, complement components 3 and 4A, fetuin-A, and
apolipoproteins A1 and B100, as well as other calcium and apatite binding proteins found in the serum. However, these
serum mineralo-protein complexes are formed from the direct chemical binding of inorganic and organic phases, bypassing
the need for any biological processes, including the long cultivation in cell culture conditions deemed necessary for the
demonstration of NB. Thus, these serum granulations may result from physiologically inherent processes that become
amplified with calcium phosphate loading or when subjected to culturing in medium. They may be viewed as simple
mineralo-protein complexes formed from the deployment of calcification-inhibitory pathways used by the body to cope
with excess calcium phosphate so as to prevent unwarranted calcification. Rather than representing novel
pathophysiological mechanisms or exotic lifeforms, these results indicate that the entities described earlier as NB most
likely originate from calcium and apatite binding factors in the serum, presumably calcification inhibitors, that upon
saturation, form seeds for HAP deposition and growth. These calcium granulations are similar to those found in organisms
throughout nature and may represent the products of more general calcium regulation pathways involved in the control of
calcium storage, retrieval, tissue deposition, and disposal.
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Introduction
Biomineralization is a general phenomenon in nature that is not
restricted to skeletal calcification alone. In fact, ectopic calcifica-
tion has been generally associated with aging and other
pathological processes. Perhaps nowhere else is ectopic calcifica-
tion more enigmatic and controversial than in the case associated
with the so-called nanobacteria (NB). These are slow growing,
pleomorphic, sub-micrometer (50–500 nm) entities coated with
proteins and containing carbonate hydroxyapatite (HAP) [1–8].
NB are supposedly associated with body fluids, blood infusion
products, and vaccines and have been linked to numerous diseases
involving extra-skeletal calcification as well as various pathologies
of infectious nature [1–8]. The putative NB found in biological
tissues are closely related to the ‘‘nannobacteria’’ found in
geological [9,10] and meteorite [11] samples that have been
presented as possible fossilized primitive precursors of biological
life. Unique 16S rDNA sequences attributed to NB were ascribed
to a new genus termed Nanobacterium, which was initially assigned
to the a-2 subclass of Proteobacteria [1,2].
In view of the unusual characteristics of the proposed NB,
deemed untenable as seen through the prism of conventional
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as lacking evidentiary support [see ref. 12 for an excellent critical
review; see also ref. 13 for a more comprehensive discussion of
related controversies surrounding the NB literature]. In an effort
to explain the biology of NB, several studies have presented
alternative views [13–16]. Cisar et al. [14] showed that NB-like
particles could be produced from saliva samples inoculated into
fresh medium without however undergoing detectable protein or
nucleic acid synthesis expected from the growth of a living entity.
Moreover, NB particles could be produced from self-propagating
HAP which was shown to nucleate on lipids like phosphatidyli-
nositol [14]. The 16S rDNA sequences previously ascribed to NB
were shown to be most likely associated with common environ-
mental microorganisms that are detected as contaminants in PCR
[14]. Raoult et al. [15], in turn, described NB as lifeless ‘‘mineralo
fetuin complexes,’’ which they termed ‘‘nanons.’’ The main
protein was identified as fetuin (referred as fetuin-A in the present
study), a result which for the first time links the biology of NB with
that of fetuin-A—an association considered paradoxical given that
fetuin-A is a calcification inhibitor [15]. ‘‘Nanons’’ were detected
with fetuin-A-specific antibodies and were shown to be cytotoxic to
several cell types tested [15]. Our own studies [13,16] showed that
serum NB can be explained by self-propagating calcium-protein
complexes that convert into HAP in the presence of phosphate. In
fact, we also showed that the NB-associated proteins turned out to
consist of calcium or apatite binding proteins found in the medium
in which NB were presumably formed. In our hands, the main
proteins associated with serum NB were shown to include
albumin, fetuin-A, apolipoproteins A1 and B100, and complement
component 3, which are not only known to have affinities for
calcium and apatite, but also are among the most abundant
proteins in the serum [13]. As calcification inhibitors, the same
proteins that bind avidly to calcium and nascent apatite are seen
here to form the scaffolds needed for further nucleation of HAP
once they are overwhelmed by the excess of calcium and
phosphate ions. This is a dual inhibition-seeding concept that
would not only explain the origin of the putative NB, but it also
would resolve the paradox of having inhibitors of calcification, like
fetuin-A, participate in the formation of the core of NB [13].
However, our own findings called for the potential inclusion of a
wider repertoire of calcium and apatite binding proteins, not just
fetuin-A, that are all able to induce the inhibition-seeding
properties needed to initiate NB-like mineral precipitation [13].
Our studies build on earlier reports [17,18] and arrives at the
conclusion that NB are lifeless, mineralo-organic entities that
nonetheless assume morphologies resembling dividing bacteria.
This is a peculiar phenomenon of ‘‘biomorphic’’ resemblance that
is also found among geological substrates containing calcite,
carbonate, and silicate compounds [19–22].
Together, these various studies point to the many fallacies
inherent in the conclusions drawn from the NB literature, and they
question the role proposed for NB in disease pathogenesis. For
one, NB can no longer be considered as some novel, primitive, and
exotic lifeforms or symbionts, as initially claimed [1,2]. To date, all
NB-proteins identified by us [13,16] have turned out to consist of
common eukaryotic proteins, a result that markedly differs from
the earlier findings of prokaryotic proteins, including porins and
complex peptidoglycans [2,23] as well as the bacterial translation
elongation factor Tu and the molecular chaperone GroEL [24], all
of which had been claimed to be associated with NB. However, in
spite of a growing consensus that views NB as lifeless entities—they
are now referred also as ‘‘calcifying nanoparticles’’ or CNP—NB
continue to be heralded as transmissible and pathogenic agents of
an alarming number of diseases that not only include renal and
arterial calcifications, but also a variety of other acute and chronic
ailments [1–8,25–28; see also refs. 12 and 13 for a list of NB-linked
diseases]. In this respect, we have found that all NB-like entities
incorporate into their scaffold the very serum proteins from the
medium used to ‘‘support’’ their culture [13]. In the case of human
tissues grown in medium containing fetal bovine serum (FBS), a
procedure commonly used by NB proponents to demonstrate the
presence of NB in human pathologies, this observation would
imply that antigenic epitopes from FBS become incorporated into
the NB scaffold. In other words, the putative NB derived from
human tissues end up harboring antigens from a different species,
creating an unprecedented scenario that compounds the difficulty
with drawing any meaningful conclusion regarding the presence of
NB in human tissues, not to mention their putative role in
pathology.
These studies indicate that the entire NB literature must be
reevaluated carefully, and that, furthermore, many of the earlier
conclusions drawn on their biology and pathophysiology must be
deemed as largely uninterpretable, if not flawed. Nonetheless, it is
clear that entities that morphologically and chemically resemble
the so-called NB can indeed form from prolonged incubation of
cell culture medium supplemented with serum and other body
fluids [13]. Armed however with a much better understanding of
the structural and chemical characteristics of NB that was
advanced through our earlier study [13], along with a growing
consensus that these entities represent lifeless mineralo-protein
complexes [13–18], we are now in a position to look for the source
of these particles in the body and to assess whether they can
perhaps be found as circulating complexes in the serum. If so, we
also seek to determine the condition in which they are present as
well as the role, if any, that these particles may have in the body
physiology.
A more thorough investigation prompted by these questions is
also justified by the fact that calcium granules or inclusion bodies
similar to NB are commonly found in nature [see Ryall’s excellent
and comprehensive review on this subject cited in ref. 29]. In fact,
such calcium carbonate or calcium phosphate granules probably
represent the most common pathways used for calcium storage,
retrieval, and disposal that are found, quoting Ryall [29], ‘‘in a
diverse range of organisms living in environments as widely apart
as water and land’’ and ‘‘spanning an enormous range of
phylogenetic complexity.’’
In this context, we demonstrate here that mineralo-protein
complexes—in the form of laminated granulations, spindles with
needle-like projections, and films—are formed directly in both
FBS and adult human serum (HS) as a result of calcium or apatite
loading and that these complexes resemble the previously
described NB as well as calcium deposits and granules seen
throughout nature. That is, NB-like precipitating particles will
readily form in the serum when this same body fluid is challenged
with calcium and/or phosphate ions, a process that does not
require the lengthy incubation usually needed to culture NB [1,2].
Furthermore, discrete proteins bound to these granulations/
complexes are found to be indistinguishable from those of NB
formed following prolonged incubation in cell cultures. Serum-
derived NB may therefore originate from the direct chemical
binding of calcium or apatite to calcification inhibitors normally
present in the serum that then become seeds for further apatite
precipitation and self-aggregation, all of which precludes the need
for any proliferation dependent on cell growth or viability. More
importantly, these same calcium phosphate complexes or
granulations can also be found in normal untreated serum, albeit
at much lower amounts, indicating that they may represent
physiological products of the normal regulatory pathways that are
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somehow become amplified as a result of calcium and/or apatite
loading. These same calcium phosphate granulations are most
likely disposed from the body, but, presumably, they may also end
up participating in either physiological or anomalous calcification
reactions. As such, these calcium/apatite granulations may have a
much more general role in the body than what had previously
been recognized.
Results and Discussion
General strategy and experimental outline
Calcification inhibitory factors in the serum with multiple
binding sites are conceptualized here to bind avidly to calcium,
phosphate, or nascent apatite that upon saturation may precipitate
to become seeding templates for further apatite growth. We
speculate that the interplay between inhibitory and seeding
influences should be physiologically relevant insofar as calcium
regulation and homeostasis are concerned. Given that human
body fluids are supersaturated with respect to calcium and
phosphate ions [30–35], it is reasonable to envision that inhibitory
forces reigning in their mutual binding and precipitation must be
at work in order for these ions to maintain solubility in the body
fluids. Likewise, it also follows that upsetting this balance, which
would occur when the same inhibitory state is overcome, should
result in the precipitation of calcium phosphate and the formation
of HAP in a manner and process that are probably repeated
throughout nature. This precipitate then needs to be disposed
from the body in order to prevent anomalous calcification.
Along this line of reasoning, the same calcium/apatite
inhibitory and seeding factors must be readily available in the
serum as well as in the other body fluids. According to this simple
model, these same calcium-binding inhibitory factors, whether
they be fetuin-A, albumin, or other binding sites, should sequester
increasing amounts of calcium ions by binding to them until the
binding sites for calcium (and/or calcium phosphate) reach
saturation. At the point of saturation, the same calcium-inhibitory
complexes would then aggregate, become insoluble, and behave as
seeds or nidi for further binding of calcium phosphate. This
propagation process would continue until microscopic entities
similar to the previously described NB and calcium granules
commonly found in nature are formed. Assuming this reasoning to
be correct, simply adding exogenous calcium or phosphate or a
combination of both directly to serum, or perhaps to any body
fluid, should produce insoluble mineralo-protein complexes, which
when introduced into fresh culture medium should in turn seed
even more apatite as well as give rise to the entire NB
phenomenology, including the properties of pleomorphism and
particle propagation. Extending this same logic, it should also be
possible to demonstrate that normal, untreated serum contains
these same circulating complexes, albeit at much lower amounts.
Structurally and functionally, these various calcium granulations
as well as the putative NB should all turn out to be virtually
indistinguishable from each other.
Formation of precipitating complexes in serum following
addition of calcium and/or phosphate
Preliminary experiments showed that concentrated solutions of
CaCl2,N a 2HPO4, or a combination of both, could be added
slowly in a drop-wise manner to either filtered FBS or HS,
followed by vigorous shaking, without resulting in immediate
precipitation. In this manner, CaCl2 could be slowly added to FBS
to concentrations as high as 50 mM without inducing precipitation
even after one hour of incubation at 37uC or after two hours of
incubation at room temperature. Likewise, under the same
incubation conditions, up to 100 mM of CaCl2 could be added
to several batches of HS without resulting in any precipitation.
The lack of precipitation in any one of these experiments could be
ascertained by centrifugation at 16,0006g at room temperature for
1 hour, which would have been expected to sediment NB-like
complexes [13]. In a similar manner, Na2HPO4 could be added
up to 30 mM to several lots of serum without any apparent
precipitation. In marked contrast, when both CaCl2 and
Na2HPO4 were added together to either FBS or HS, precipita-
tions appeared readily when as low as 3 mM of each ion were
introduced, indicating that the propensity for precipitation greatly
increased when both ions were added simultaneously.
On the other hand, these same preliminary experiments also
revealed a marked variability of results depending on the lot of
serum used. That is, different batches of FBS and HS produced
significant differences in the extent of ion-triggered precipitation.
Significant differences were also noticed depending on the age of
the serum lot tested. Compared to fresh serum for example, aged
serum (e.g., serum that had been stored for several weeks) tended
to produce precipitates more readily when the same amounts of
calcium and/or phosphate were added. As a result of aging, some
batches of serum were seen to produce precipitates spontaneously
through storage alone and without any ion treatment, but in
general untreated serum produced little or no visible precipitation
upon centrifugation.
The same experiments also revealed marked differences in
precipitation depending on the length of incubation allowed
following the addition of CaCl2 and Na2HPO4 (for brevity, these
will be referred respectively as calcium and phosphate treatments
in the text). Thus, while short incubations as described above did
not lead to any visible precipitation when individual ions were
added even to artificially high concentrations, prolonging the
incubation after the same serum treatment produced steady
precipitation as a function of time. In fact, either calcium or
phosphate produced precipitation when added to 6 mM or 3 mM,
respectively, provided that the subsequent incubation was
prolonged to 2 hours at 37uC or overnight at room temperature.
Likewise, under these incubation conditions, precipitation was
observed when both calcium and phosphate were added together
to as little as 1 mM each. With longer periods of incubation, the
precipitating concentrations of the same ions could be further
reduced. For some serum batches, precipitation was noticed with
as little as 0.1 mM calcium phosphate added when the subsequent
incubation was lengthened to 48–72 hours at 37uC.
Precipitating calcium and apatite complexes prepared in
serum can seed self-propagating particles resembling NB
In all instances of serum treatment with precipitating ions,
white, granular precipitates that could be dispersed in solution
became visible. In the presence of excess calcium, pellets appeared
granular and fluffy to the eye, while the excess of phosphate
produced gelatinous, grayish pellets that appeared more clumpy
and resistant to dispersion even by vigorous shaking. These visual
characteristics could be easily modulated by adding different
amounts of calcium and phosphate.
Next, for purposes of seeing whether these same pellets were
capable of seeding NB-like particles, they were collected by
centrifugation, washed, and serially transferred into fresh, new
medium. Figure 1 illustrates dose-dependent experiments in which
FBS pellets were first obtained after serum treatment with the
indicated amounts of ions, and then inoculated into serum-free
Dulbecco’s Modified Eagle’s Medium (DMEM). Inoculation of the
serum pellets into DMEM did not produce any turbidity initially
Calcium Granulations in Serum
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A–D, wells 2–10, corresponding to the first day of inoculation), but
following incubation at 37uC in cell culture conditions, pellets
inoculated into serum-free DMEM developed precipitates steadily
over time in a dose-dependent manner that became noticeable to
the naked eye or through A650 reading by the third day of
incubation and that increased thereafter. In Figure 1, data
collected on days 4 and 8 are shown to illustrate a time-dependent
as well as dose-dependent increase in the amount of precipitation
formed following the initial inoculation (Fig. 1, ‘‘Day 4’’ and top
‘‘Day 8’’ panels, rows A–D, wells 2–10). The amount of
precipitation increased less after the first week, and by the end
of the second week, it was seen to plateau (not shown). From these
data, it is clear that serum pellets obtained and processed in this
manner displayed clear particle-seeding activity that could not be
attributed solely to the initial inocula since the turbidity was seen
to increase over time.
In the case of calcium, a clear dose-dependent effect could be
seen when calcium was added to FBS to a final concentration
between 12 and 48 mM, followed by inoculation of the obtained
pellets into serum-free DMEM and incubation for several days
(Fig. 1, ‘‘Day 4’’ and top ‘‘Day 8’’ panels, rows A–D, wells 2–5).
This dose-dependent effect was obvious depending on the amount
of calcium initially added to the serum, with more calcium
conferring greater seeding potential (in Fig. 1, ‘‘Day 4’’ and top
‘‘Day 8’’ panels, rows A–D, compare wells 2–5; note the dose-
dependent effect going from left to right). Furthermore, for each
concentration of calcium initially added to induce pellet formation,
a dose-dependent effect could also be seen for the amount of FBS-
pellet used for inoculation into serum-free DMEM, with larger
serum pellets inducing larger NB-like precipitates (Fig. 1, ‘‘Day 4’’
and top ‘‘Day 8’’ panels; note a dose-dependent effect within the
same panel going from top to bottom, that is, from wells B to D,
corresponding to the inoculation of 2 mlt o1 5ml of FBS-pellet,
respectively). Similar results were obtained with HS pellets (not
shown).
Alternatively, serum pellets could be serially transferred to new
medium at 1:5 dilution for at least 5 cycles, indicating a self-
propagating nature similar to what had been reported earlier for
NB [1–8]. However, the precipitates were seen to decrease in size
with each transfer into serum-free DMEM; a similar decrease in
precipitate volume was also seen with the serial transfer of several
strains of NB into serum-free medium (see Materials and Methods;
data not shown).
FBS that had been treated with phosphate alone also produced
pellets (Fig. 1, ‘‘Day 4’’ and top ‘‘Day 8’’ panels, with wells marked
by columns 6–8 corresponding to a range of 6–24 mM of
phosphate, respectively). Like calcium, phosphate also produced
similar dose-dependent effects (compare wells in columns 6–8 with
columns 2–5, Fig. 1, ‘‘Day 4’’ and top ‘‘Day 8’’ panels, with an
increase in precipitation from columns 6 to 8; observe also the
increase in precipitation within the same panel from wells 6B to
6D; 7B to 7D, and 8B to 8D, that is, within each column).
As noted earlier, serum pellets were more effectively produced
by a combination of calcium and phosphate added together. In
fact, FBS-pellets produced by the addition of calcium and
phosphate at the relatively low concentration of 1 mM each,
followed by a 2-hour or overnight incubation, displayed clear
particle-seeding activity when subsequently inoculated into serum-
free DMEM (Fig. 1, ‘‘Day 4’’ and top ‘‘Day 8’’ panels; compare
columns 9 and 10 within the same panel; compare also for
example well 10B with wells 10C and 10D within the same panel).
As before, a distinct dose-dependence could be discerned with the
amount of calcium phosphate added initially to obtain the serum
pellet as well as with the final pellet volume used for inoculation
into DMEM (Fig. 1, ‘‘Day 4’’ and top ‘‘Day 8’’ panels; compare
rows B, C, and D for each column as well as among columns 9 and
10 within the same panel). The mineral pellets initially tended to
aggregate at the center of each well until they dispersed to
resemble membrane-like formations. Similar results were also
obtained with HS-pellets (data not shown).
The experiments shown in Figure 1, done with excess calcium
or phosphate added to serum, demonstrate the marked capacity of
both FBS and HS to absorb exogenously added ions, resulting in
little or no precipitation. However, upon prolonged incubation of
calcium- or phosphate-treated serum at 37uC for a period of
several days or weeks, we noticed precipitation with much lower
amounts of either ion added (1–10 mM each of either calcium or
phosphate and 0.1–1 mM of each with calcium and phosphate
combined). The pellets obtained under these conditions also
showed clear particle-seeding activity. Likewise, increasing the
speed of centrifugation to 140,0006g for 1 hour significantly
increased the size of the pellet obtained (data not shown),
indicating that some of the complexes may have remained in
suspension in the ion-treated serum following the lower-speed
centrifugation (16,0006g) used before.
None of the control wells containing only DMEM and devoid of
any serum-derived materials produced any significant amounts of
precipitates, as discerned visually or through A650 reading
following the same 3-day incubation (Fig. 1, in each one of the
5 panels). Significantly, control FBS that had not received
exogenous calcium or phosphate produced a small precipitate
after centrifugation, but this material did not lead to the nucleation
of any significant amount of precipitates during the same 4-day
period of observation under the conditions used (see Fig. 1,
column 1 of the ‘‘Day 4’’ panel) or even after prolonged
incubation for 1 week (Fig. 1, column 1 of the top ‘‘Day 8’’
panel). This important negative control indicated that the seeding
factor seen here could not be attributed solely to any insoluble
matter or debris present in FBS prior to the addition of calcium
Figure 1. Calcium and phosphate added to serum produce particle-seeding pellets. Serum pellets were obtained by adding calcium and/
or phosphate to FBS to the amounts indicated at the top and incubated overnight at room temperature. Treatment of serum was divided into 4
groups of ions added: no exogenous ions (column 1, ‘‘None’’); CaCl2 (columns 2–5, referred as ‘‘Calcium,’’ 12–48 mM); Na2HPO4 (columns 6–8,
‘‘Phosphate,’’ 6–24 mM); and a combination of both CaCl2 and Na2HPO4 (columns 9 and 10, ‘‘Calcium+Phosphate,’’ at either 1 mM or 2 mM each).
After overnight incubation, the pellets were obtained and processed as described in the Materials and Methods. The resuspended pellets were
inoculated into either serum-free DMEM (rows A–D, top 3 panels), calcium-free DMEM (rows A–D, 4
th panel from top), or phosphate-free DMEM (rows
A–D, bottom panel) in the same order, as three exact replicas. The amount of resuspended pellet volume inoculated into each well is depicted on the
left. Observations were done on days 1, 4, and 8 for the top three panels and on day 8 for the bottom two. All incubations were done at 37uC in cell
culture conditions. The wells in column 1 corresponded to inoculation with serum pellets obtained from FBS without any ion treatment, while the
wells in row A represented control DMEM, without any pellet inoculation. These controls showed no turbidity by visual inspection. On the other hand,
turbidity and the presence of precipitates could be seen in all the other wells of the ‘‘Day 4’’ and ‘‘Day 8’’ panels. The wells of the 4
th panel,
corresponding to incubation in DMEM without calcium, did not show any precipitate whereas the bottom panel wells (DMEM without phosphate)
produced small amounts of precipitates.
doi:10.1371/journal.pone.0005421.g001
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initial double filtration of serum through both 0.2 m and 0.1 m
membranes was intended to remove as much insoluble material as
possible from the FBS lots used in this study. It should be pointed
out however that the negative results obtained with untreated
serum pellets were not absolute since larger amounts of this
untreated serum pellet did indeed produce NB-like precipitates
upon subsequent inoculation into DMEM (not shown); likewise,
upon longer incubations up to 1 month in DMEM, precipitates
could be detected, albeit at much lower levels when compared
with the other serum pellets mentioned earlier (not shown). Again,
the various lots of serum produced widely different amounts of
pellet upon centrifugation. Moreover, by increasing the speed of
centrifugation to 140,0006g or by storing the serum batch for
several weeks at 4uC, a significantly larger amount of pellet could
be obtained from untreated serum, suggesting again that
circulating calcium-phosphate-complexes in the serum, if any,
may remain initially in solution until heavier loads of calcium and
phosphate are added that result in binding, saturation, and
precipitation. It is also obvious that this same propensity for
precipitation can be induced in the case of untreated control
serum either by higher speed of centrifugation or by prolonged
storage conditions. Together, these results suggest that while
adding exogenous calcium and phosphate to serum results in the
formation of precipitating complexes, this same process may occur
in control, untreated serum as well, albeit at much slower rates.
An additional control was done to assess whether the NB
seeding activity observed here with serum pellets is dependent on
the presence of both calcium and phosphate present in the
inoculated medium. As shown in the two bottom panels of
Figure 1, we inoculated the various serum pellets into DMEM that
lacked either calcium or phosphate. No significant amount of
precipitate was generated under these conditions even after several
days of incubation in cell culture conditions. Together, these
experiments reveal that serum can sequester excess calcium and
phosphate until precipitating complexes are formed, which in turn
seed further particle growth only in the presence of both calcium
and phosphate in the surrounding milieu. Our experiments also
show that either calcium or phosphate added alone to serum is
sufficient to generate precipitation, but only when the ions are
added to artificially high concentrations. The high absorption
capacities for calcium or phosphate displayed by serum attests to
the efficacy of the built-in inhibitory mechanisms used to prevent
calcification. On the other hand, when added simultaneously to
serum, calcium and phosphate trigger precipitation at much lower
ion levels, indicating that the same inherent calcification-inhibitory
mechanisms are much more easily overcome when both
precipitating ions are present.
Precipitating serum complexes appear as calcium and
apatite granulations that resemble morphologically both
bovine and human NB
We next examined the morphology of serum pellets obtained
through the addition of either calcium or phosphate, or a
combination of these two ions. Various low and high resolution
microscopies were used. For easier referencing of the individual
images within the figure composites shown as Figures 2, 3, 4, 5, 6,
7, 8, 9,10 and for purposes of abbreviation, we adopted the
following nomenclature. In addition to the identifying letters used
for each figure, all figures were also labeled as either FBS- or HS-
followed by a number code, explained as follows. FBS-1/HS-1
represented serum pellets from FBS or HS, respectively, obtained
under untreated conditions and used as controls; FBS-2/HS-2
corresponded to the addition of calcium alone to the serum sample
prior to incubation and centrifugation; FBS-3/HS-3 corresponded
to the addition of phosphate alone; and FBS-4/HS-4 correspond-
ed to the addition of both calcium and phosphate.
By dark field microscopy and in the absence of ion treatment,
both FBS and HS pellets (FBS-1 and HS-1) produced little
detectable material that appeared as highly refringent and
heterogeneous particles as well as patches varying in size markedly
between 0.1 to 10 mm (Fig. 2A and E, respectively). This strong
refringence as seen by dark field microscopy is probably due to the
optically dense walls of these particles, which also make the same
particles easily discernible by phase contrast microscopy in the
absence of any staining (not shown).
Upon addition of calcium or phosphate to serum, however,
pellets showed a large number of smaller and more homogeneous
particles with sizes typically under 200 nm (Fig. 2B and C). On
higher magnification under a dark field microscope, the particles
appeared to display a refringent membrane-like contour (not
shown). Upon addition of both calcium and phosphate, the
particles appeared to aggregate, forming large patches within
which the individual spheroid particles could still be discerned
(Fig. 2D and H). The granular patch or film was not restricted only
to treatment with both calcium and phosphate; serum treated with
either calcium or phosphate alone generated pellets that eventually
converted to this same morphology. For purposes of illustration,
both Figure 2F and G clearly display the granular-patch
morphology. With prolonged storage for 1–2 weeks, even at
4uC, we noticed that all pellet samples appeared to transition from
the small spherical particle shapes to the granular membranous
patches, and these in turn appeared to aggregate further until only
the larger clumps of refringent material were left, at the expense of
the individual spherical shapes, which were eventually lost (not
shown). Compared to the calcium-phosphate-treated serum
pellets, the control untreated pellets gave comparable dark field
images except for the much smaller amounts of precipitate
material seen (Fig. 2A and E).
These images were remarkably similar to those obtained from
previously characterized NB and chosen as controls in our study
(Fig. 2I–K). To make sure that our controls were indeed
representative of NB reported in the literature, we took into
account first that all NB described to date had been derived from
cell cultures initially containing serum, usually FBS or HS at 10%,
that were then subcultured through serial passage (referred here as
either FBS-NB or HS-NB, abbreviated respectively from the more
precise terms FBS-derived NB or HS-derived NB) [1,2]. Figure 2I
shows an example of HS-NB that had been cultured in DMEM
inoculated with 10% HS collected from a healthy donor, exactly as
described in the protocols published earlier [1,2] and outlined in
the Materials and Methods. In addition, we used the earlier described
‘‘NB strains’’ derived from cell culture medium inoculated with
10% FBS, which included three strains of putative Nanobacterium
sp. that were deposited by Kajander with the German Collection
of Microorganisms (referred by their serial codes DSM 5819–
5821) [23,36] as well as the Nanobacterium sp. strain Seralab 901045
used by Raoult et al. [15], which they have called ‘‘nanons’’ (see
Fig. 2J for ‘‘nanons’’ and Fig. 2K for one of the three DSM
strains). We reasoned that these controls would allow comparison
of our data with both bovine and human NB, while the use of
previously characterized NB ‘‘strains’’ would remove any doubt
concerning their origin or representation. As can be seen in
Figure 2I–K, an array of morphologies could be discerned again
that included spherical particles (shown for ‘‘nanons,’’ Fig. 2J),
granular patches showing the spherical aggregated particles (DSM
5820, Fig. 2K), and clumps of smooth refringent material no
longer containing any evidence of round particles (HS-NB, Fig. 2I).
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identical to those seen with the serum pellet particles. As an
additional control, chemically synthesized HAP was also photo-
graphed to show its typical monolithic solid morphology (Fig. 2L).
Serum pellets were next studied by higher resolution imaging
techniques like scanning electron microscopy (SEM) and trans-
mission electron microscopy (TEM) (Figs. 3–5). As seen by both
SEM (Fig. 3) and TEM (Figs. 4 and 5), these pellets gave a wide
spectrum of morphologies, ranging from round, 20–200 nm
particles to coalesced mattresses or films. On average, the size of
the round particles seen in the HS pellets (at 20–150 nm) was
smaller than those seen in pellets prepared in FBS (see Fig. 3B and
F depicting SEM images of pellets obtained from FBS and HS,
respectively). In addition, the size of the particles seen in the serum
pellets was generally smaller than the earlier observed NB
produced in DMEM (Fig. 3I–L) which could be due to culture
conditions, with the NB having gone through either prolonged cell
cultivation in the case of HS or FBS-NB or multiple serial passages
in the case of the NB strains ‘‘nanons’’ and DSM 5820 [13].
In the presence of exogenous phosphate, the round particles
were seen to rapidly coalesce into aggregates that looked like the
granular mattresses seen earlier with dark field microscopy (Fig. 2D
and F–H). Different stages of this aggregation could be seen
sometimes within the same specimens, with some sections
appearing more granular, presumably indicating an earlier stage
of aggregation (Fig. 3G and H), while others appearing as
filaments or mattresses, into which the individual round particles
had presumably fused (Fig. 3C and D).
Control, untreated serum pellets also displayed a whole array of
shapes. Most appeared as poorly defined structures with
amorphous and heterogeneous shapes (shown for HS-1 in
Fig. 3E). However, in all the control pellets that we examined,
occasional patches of round particles or mattresses could be seen.
Figure 3A shows an example of granular pattern seen with control
FBS-1 pellet that is virtually indistinguishable from others that
have been treated with calcium or phosphate (compare for
instance Fig. 3A with 3B).
These morphologies were remarkably similar to those seen with
NB (Fig. 3I–L). For purposes of illustration, we used four samples
of NB as control, comprised in turn of two NB cultures derived
directly from DMEM inoculated with FBS or HS, and 2 NB
strains grown in FBS. The morphology of NB was seen to vary
markedly with culture conditions like the length of incubation, the
initial inoculum size, and the presence or absence of serum. NB
were typically of round shape when first formed and they were
retained largely as particles in the presence of 3 to 10% serum
(Fig. 3I–L), but they gradually aggregated into needle-containing
spindles which in turn gave way to films and mattresses (not
shown). In the absence of serum, NB rapidly converted into larger
semi-spherical forms that have also been called ‘‘shelters,’’
Figure 2. Serum pellets and NB have similar pleomorphic morphologies under dark field microscopy. Serum pellets were prepared
from untreated serum (A and E) or following addition of either 48 mM CaCl2 (B and F), 24 mM Na2HPO4 (C and G), or a combination of both 2 mM
CaCl2 and 2 mM Na2HPO4 (D and H) to the indicated serum, followed by incubation at room temperature overnight, centrifugation, and washing
steps as described in the Materials and Methods. Low amounts of large heterogeneous particles were noted in the untreated serum pellets (A and E)
while the other serum pellets (B–D, F–H) produced smaller and more homogeneous round particles. Such round particles tended to aggregate
forming clumps and granular patches (D, F–H). Note that individual granules can be discerned against a background of aggregated material. Similar
morphologies were noted in the controls, with HS-NB (I) showing an aggregated diffuse mass in which granules are embedded; ‘‘nanons’’ (J) as
dispersed round particles; and DSM 5820 (K) as clumps of highly refringent particles. (L) HAP is shown for comparison. Scale bars: 10 mm.
doi:10.1371/journal.pone.0005421.g002
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into membranes or films. Some spheroid particles showed a
gradual loss of their smooth surfaces, acquiring instead needle
projections or whiskers (more noticeable with the two controls HS-
NB and FBS-NB seen in Fig. 3I and J). Others, resembling the
serum particles shown earlier, displayed the appearance of
mattresses in which fusing or fading spherical particles could be
barely discerned or were altogether lost, presumably due to a
continuous process of aggregation (not shown).
It should be noted that the morphologies described here for the
serum pellets and NB are reminiscent of the calcium phosphate
nanoparticles seen in other kinds of calcifications, as for example seen
with osteoblast cultures [37] or with tumors [38]. Round nanopar-
ticles of HAP remarkably similar to our serum pellets have also been
found in association with calcifications found in animals [39].
TEM of unstained serum pellets provided another morpholog-
ical aspect not apparent from SEM analysis that further illustrated
the marked heterogeneity displayed by these serum entities. The
round granular shapes of serum pellets (Fig. 4F and G) were seen
to aggregate into larger structures (Fig. 4C) that in turn seemed to
elongate into ellipsoid shapes or spindles carrying projecting
needles or filaments (Fig. 3B, D, and H). Higher magnification
showed that the these filamentous structures appeared to be
derived from the fusion of the individual spheres following co-
linear deposition patterns, while the stacks or spindles of filaments
appeared to form from the juxtaposition of the individual needles
(not shown). These morphologies closely resembled the so-called
‘‘secondary calciprotein particles’’ (the term ‘‘calciprotein parti-
cles’’ is abbreviated as CPP in the present study) formed by fetuin-
albumin-mineral complexes that also appear shaped as ‘‘prolate
ellipsoids,’’ as described by Heiss and co-workers [30,40,41].
Particles resembling secondary CPP and the serum pellets
described here have been isolated recently from the ascites of a
patient suffering from calcifying peritonitis indicating that such
Figure 3. Morphology of serum pellet granulations seen under SEM demonstrates resemblance to NB. Serum pellets were prepared as
in Fig. 2 from untreated serum (A and E) or after addition of either CaCl2 (B and F), Na2HPO4 (C and G), or a combination of both CaCl2 and Na2HPO4
(D and H) to the indicated serum (amounts of ions added as described in Materials and Methods). Serum pellets primarily harbored round particles in
FBS pellets (A–C) and these particles tended to be smaller in HS (E–G). Treatment with both CaCl2 and Na2HPO4 produced particles undergoing
different stages of crystallization and film coalescence as well as needle-like projections or spindles (D and H). The morphologies of the serum pellets
were similar to the NB controls obtained from either 10% HS (I) or 10% FBS (J) as well as to the NB strains ‘‘nanons’’ (K) and DSM 5820 (L), even though
the sizes of the serum pellets particles tended to be smaller than NB. Note that while both ‘‘nanons’’ and DSM 5820 showed smooth surfaces, HS-NB
and FBS-NB appeared with rough surfaces containing needle-like crystalline projections. Scale bars: 100 nm (B); 250 nm (C–E, G, H); 300 nm (F, L);
500 nm (I, J); 600 nm (K); 1 mm (A).
doi:10.1371/journal.pone.0005421.g003
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PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5421Figure 4. Morphology of unstained serum pellet particles observed by TEM shows similarity to NB. Serum pellets were prepared from
untreated serum (A and E) or after addition of either CaCl2 (B and F), Na2HPO4 (C and G), or both (D and H) to the indicated serum, followed by
preparation for TEM. Samples were viewed without fixation or staining. The serum pellets displayed various morphologies including round particles
(A, C, F, and G) while other samples harbored spindles with more crystalline appearance (B, D, E, and H). In general, the combination of calcium and
phosphate tended to produce more readily spindles with needle-like crystalline projections (D and H). The various NB controls shown in the bottom
two rows were displayed to show comparable morphologies with predominant round particle shapes (3
rd row) or more crystalline aggregates (4
th
row). However, morphological variations can still be seen within each row. Thus, NB cultured directly from 10% HS (I) or 10% FBS (J) displayed
predominantly chain-linked ovoid or spherical shapes resembling dividing bacteria. In contrast, the NB strains ‘‘nanons’’(K) and DSM 5820 (L) shown
here appear further along in their crystallization and while they have retained ovoid shapes, they also show more pronounced fusion and
aggregation. In the case of ‘‘nanons’’ (K), there are noticeable thick walls that appear less electron-dense than the core, presumably formed of
minerals. For DSM 5820 (L), crystalline bridges can be seen connecting the fused ovoid particles. (M–P) show further progression in aggregation and
crystallization, with the appearance of coalesced films (more noticeable in N and P). Film-like aggregation is generally seen with longer periods of
incubation or by reducing the amount of serum in the culture medium (to less than 3%). Scale bars: 50 nm (C, G, H, J); 100 nm (A, D, F, N, P); 200 nm
(B, E, I, K–M, O).
doi:10.1371/journal.pone.0005421.g004
Calcium Granulations in Serum
PLoS ONE | www.plosone.org 9 May 2009 | Volume 4 | Issue 5 | e5421Figure 5. Morphological resemblance between serum pellets and NB as seen by thin section TEM. Serum pellets obtained from
untreated serum (A and E) or after addition of either CaCl2 (B and F), Na2HPO4 (C and G), or a combination of both (D, H–L) to the indicated serum,
were processed for thin section TEM as described in the Materials and Methods. The FBS pellets (A–D) show spindles in various stages of crystallization
and aggregation, with (A and B) consisting of smaller filamentous stacks while (C and D) show spindles in the process of fusion and coalescence,
Calcium Granulations in Serum
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pathological conditions when there is excess calcium loading [30].
For the serum pellets, the amount of needle-like crystalline
projections increased with the length of incubation after the
addition of the various precipitating ions and prior to the
centrifugation step used to obtain serum pellets. In fact, serum
pellets that had been centrifuged immediately after addition of
calcium and phosphate and that had been washed and stored at
4uC for one week also spontaneously converted from round
particles to crystalline needle-like patterns, a behavior identical to
Figure 6. Powder X-ray diffraction spectra of serum granulations demonstrating both amorphous and crystalline patterns. Serum
granulations (pellets) were obtained from either untreated serum (A and F) or following treatments with CaCl2 (B and D) or a combination of CaCl2
and Na2HPO4 (C and E) to the indicated serum, and were dried prior to XRD analysis. Note that the XRD spectra include amorphous patterns (A–C)
and peaks corresponding to crystalline compounds of Ca(H2PO4)2?H2O (D) and Ca10(PO4)6(OH)2 (E and F). Crystalline patterns were seen associated
with both calcium (D) and calcium phosphate-treated sera (E) as well as untreated serum (F), whereas amorphous patterns were seen not only with
untreated serum (A), but also with calcium-treated (B) and calcium phosphate-treated sera (C). XRD spectra corresponding to Ca10(PO4)6(OH)2 were
obtained for NB cultured from 10% HS (G) or 10% FBS (H) as well as commercially available HAP used for comparison.
doi:10.1371/journal.pone.0005421.g006
presumably to form crystallized films. On the other hand, the HS granulations (E–H) show predominantly round particles with a diameter between 20
to 100 nm. (I–L) represent magnified images of serum granulation specimens to illustrate marked pleomorphism and heterogeneity within the
samples prepared in FBS (I–K) or HS (L). (I and J) show FBS-4 round particles appearing with thick, single walls, which appear to represent precursors
to the larger fused ovoid particles containing crystallized needle-like projections (K). These appear to coalesce further until they form the spindles
appearing as stacks of crystalline filaments arranged co-linearly, shown here for HS-4 (L); note that the various HS samples appear predominantly as
round shapes, thus this image was shown to emphasize the phenomenon of pleomorphism. Large structures with ring-like formations were
characteristic of NB cultured directly from 10% HS (M–P) and ‘‘nanons’’ cultured in 10% FBS (Q–T). In (S), ‘‘nanons’’ can be seen to be fusing to form
stacks of filaments. Note the presence of spherical shapes with two (Q), three (R and S), and four (T) concentric rings of electron-dense material. In
general, ‘‘nanons’’ (Q–T) tended to be larger than the similar formations seen in the serum pellets (K and L). Scale bars: 50 nm (E, I–L); 100 nm (B–D, F–
H, O, P), 200 nm (A, M, N, S); 300 nm (T); 500 nm (Q, R).
doi:10.1371/journal.pone.0005421.g005
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shown; refer to ref. 13 for a more detailed discussion of this
conversion).
As noted earlier, serum that had not been treated with
precipitating ions produced very little pellet; this pellet gave
principally images of amorphous, poorly-defined shapes with
heterogeneous sizes not seen with the other serum pellets prepared
by ion loading (see Fig. 3E shown for HS-1 and Fig. 4A for FBS-1).
Occasionally, however, in some control pellets, the same ellipsoid
spindles carrying stacks of filaments or needles could be seen
(Fig. 4E, shown here for HS-1). Thus, although small in size by
comparison, the control serum pellets appeared to display the
same plethora of shapes seen associated with ion treatment and
that include both spherical particle (Fig. 3A) and filamentous
spindle (Fig. 4E) morphologies.
The images obtained for these serum pellets were remarkably
similartothosecollectedforbovineandhumanNB(showninFig.4I–
P). In the presence of serum (3–10%), both bovine and human NB
appeared as spherical particles (3
rd row, Fig. 4I–L, shown here for
both HS-NB and FBS-NB as well as for the two strains of NB known
as ‘‘nanons’’ and DSM 5820). In the absence of serum or by allowing
them to age in culture, the NB particles appeared also to coalesce into
spindles and films, (bottom row, Fig. 4M–P), producing images that
were similar to those obtained earlier for the serum pellets.
Figure 7. Energy-dispersive X-ray spectroscopy of the serum granulations reveals a broad spectrum of compositions similar to NB.
Serum granulations (pellets) were obtained as before from untreated serum (A and E) or after addition of either CaCl2 (B and F), Na2HPO4 (C and G), or
a combination of both (D and H) to the indicated serum. EDX spectra were also obtained for NB cultured from HS (I) or for two NB strains cultured in
FBS (J and K). Commercial reagents of CaCO3 (L), calcium phosphate labeled as Ca3(PO4)2 (M), and HAP (N) were used for comparisons. Serum
granulations were also prepared by adding CaCl2 to FBS followed by incubation for 1 hour (O) or overnight (P) at room temperature. The following
Ca/P ratios were obtained: (B) 1.31; (C–E) 1.33; (F) 1.86; (G) 1.3; (H) 1.24; (I) 1.28; (J) 1.36; (K) 1.31; (M) 1.31; (N) 1.63; (O) 5.42; and (P) 1.24. In (A) and (L),
Ca and P were not detected. The presence of C in some samples might be attributed in part to the formvar carbon-coated grids used as support for
the analysis.
doi:10.1371/journal.pone.0005421.g007
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displayed either the round particle (Fig. 5E–H) or the spindle-like
morphologies (Fig. 5A–D). The progression of morphological
change from round particles to stacks of spindle-shaped filamen-
tous networks was a function of the kind of precipitating ions used,
with phosphate and a combination of calcium and phosphate
giving more readily spindle shapes as compared with calcium
treatment alone. In line with earlier results, either longer
incubation times following the treatment of serum with precipi-
tating ions or longer storage of the prepared and washed pellets
could each enhance the transformation of round particles into
spindles and films. In general, however, any of the specimens
studied was seen to display a broad spectrum of morphologies. For
instance, although the FBS pellets were shown mainly to illustrate
filamentous and needle-like crystalline projections (Fig. 5A–D, K
and L), in the same specimens round morphologies were also
readily seen (Fig. 5I and J). Needle-like projections or whiskers
could also be seen radiating from the surface of some particles,
which appeared to be undergoing a gradual transformation from
round particles to spindles (Fig. 5D and K). FBS pellets obtained
through both calcium and phosphate treatments tended to
produce stacks or spindles of larger crystalline filaments with
longitudinal lengths reaching upwards of 250 nm (Fig. 5D, K, and
L). On the other hand, the HS pellets shown here harbored round
particles of small sizes with diameters ranging from 20 to 100 nm
(Fig. 5E–H). Some of the round particles seen in the HS pellets
were found to possess an electron-dense wall with either electron-
pervious or dense amorphous core material (Fig. 5G and H) while
others appeared to harbor semi-crystalline material with lower
electron-density (Fig. 5F and G). With prolonged incubation of
serum with calcium and phosphate, the same granulations were
seen to also acquire multi-layered walls (not shown). In addition,
when serum granulations were transferred to DMEM containing
serum (1–10% FBS), the same particles were seen to grow further
in size and to acquire eventually concentric layers of alternating
densities with prolonged incubation (not shown).
These morphologies were similar to those seen for NB as
exemplified here by both NB obtained from serum-containing
medium as well as the NB strain ‘‘nanons’’ (Fig. 5M–T). As before,
a variety of distinct morphologies could be seen. Small single-
walled spherical particles were generally associated with the initial
NB population (Fig. 5M). However, with prolonged incubation,
there was either a thickening of the spherical walls or a conversion
to larger, multi-layered, concentric spheres (Fig. 5N). Alternatively,
there was also conversion from spherical shapes to filamentous
spindles or stacks (Fig. 5O and P; see also Fig. 5S for an image of
‘‘nanons’’ undergoing transformation from a round particle shape
to that of a filamentous spindle). At times, needles or filaments
could be seen projecting from the spheres until these became
elongated to resemble spindles (Fig. 5O and P).
Figure 8. Fourier-transformed infrared spectroscopy of serum
granulations reveals the presence of carbonate and phos-
phate. Serum granulations (pellets) were prepared from untreated
serum (A and E) or following addition of either CaCl2 (B and F), Na2HPO4
(C and G), or a combination of both (D and H) to the indicated serum.
The FTIR spectra of the serum granulations revealed peaks characteristic
of phosphate at 575 cm
21,6 0 5 c m
21,9 6 0 c m
21, and 1,000–
1,150 cm
21 as well as carbonate at 875 cm
21 and 1,400–1,430 cm
21.
Peaks corresponding to amide I, II, and III near 1,660 cm
21, 1,550 cm
21,
and 1,250 cm
21, respectively, were also noted in the serum granula-
tions (A–H) probably corresponding to the presence of proteins from
the serum used. NB cultured from 10% healthy HS incubated in DMEM
for one month (I) and the NB strain ‘‘nanons’’ cultured in 10% FBS (J)
showed FTIR spectra identical to those of serum granulations except for
the amide peaks which were of lower intensity for amide I and were
absent for amide II. Note that the presence of residual water seen in the
controls (K–M) at 1,650 cm
21 could also contribute to the intensity of
the peak corresponding to amide I. Commercially available CaCO3 (K),
Ca3(PO4)2 (L), and HAP (M) were included for comparison.
doi:10.1371/journal.pone.0005421.g008
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alternating electron-dense and pervious layers resembling ‘‘bull’s
eyes,’’ could be more clearly seen with NB ‘‘strains’’ that had been
maintained through multiple serial passages in the presence of
excess serum (5–10% FBS), as illustrated by thin section images of
‘‘nanons’’ shown in the bottom row of Figure 5 (Q–T). In addition
to much larger sizes (some reaching micron sizes), ‘‘nanons’’ were
seen here to display the characteristic ‘‘tree-age-ring-like’’
laminated morphology typical of NB [2,28].
Similar images are also associated with calcium granules
commonly found in nature [see Ryall’s review cited in ref. 29 in
which she shows a gallery of thin section images depicting
transversal sections of granules obtained from organisms covering
a wide range of phylogenetic complexity and that are virtually
indistinguishable from the round particles seen here; compare her
Figs. 5 and 10 with our Fig. 5]. In contrast however to NB and the
many well-established granules found in nature, the serum pellets
studied here showed predominantly spherical particle shapes with
single walls, with only a minority displaying the variegated, multi-
layered laminated morphology. In the case of calcium granules,
the alternating electron dense and pervious layers have been
interpreted as reflecting the intercalation of organic and mineral
layers, respectively [reviewed in ref. 29], a formation that may also
require prolonged time of incubation or storage.
It should also be noted that the serum pellets studied here
display marked pleomorphism, with morphologies that include
granular as well as membranous and filamentous patches, while
the calcium granules described earlier were noted mainly for their
spherical, laminated shapes [29]. In order to take into account the
marked pleomorphism described here, the serum pellets are also
referred as ‘‘serum granulations’’ throughout the text so that they
may be distinguished morphologically, at least for the time being,
from the predominantly spherical laminated shapes associated
with the calcium granules described elsewhere [29]. It is likely that
in the presence of excess calcium and phosphate the same
spherical calcium granules described elsewhere [29] may also
continue to sediment apatite and assume pleomorphic shapes that
include films and mattresses. In fact, in the case of Randall’s
plaque found in the kidneys, the granules comprising the plaque
not only carry the characteristic laminated and variegated
spherical morphologies, but they are also seen as a thin layer or
‘‘plaque’’ that eventually covers the basal membrane of the thin
loop of Henle ´, spreading beneath the tubular epithelium [29].
More studies will be needed to ascertain whether all round calcium
particles will eventually coalesce to form the spindles and films
seen here with our serum granulations.
Chemical composition of serum-derived calcium and
apatite granulations
The chemical composition of the serum granulations was
established using a combination of spectroscopy techniques.
Powder X-ray diffraction (XRD) analysis of the serum granula-
tions yielded a wide repertoire of amorphous (Fig. 6B and C,
shown for HS-2 and HS-4, respectively) and crystalline patterns
(Fig. 6D and E, shown for FBS-2 and FBS-4, respectively). In
general, these patterns reflected a transition from amorphous
particles to Ca10 HAP crystals. For the small serum pellets
obtained from control serum, amorphous patterns predominated
(Fig. 6A, FBS-1), but infrequently, HAP crystals were also detected
(Fig. 6F, HS-1).
Like SEM and TEM, the XRD analysis also revealed great
variability with regard to amorphous and crystalline patterns
obtained for the various specimens studied. Thus, in some
specimens, amorphous patterns were retained even in the presence
Figure 9. Micro-Raman spectroscopy shows similar chemical
compositions for the serum granulations and NB. Serum
granulations (pellets) obtained from untreated serum (A and E) or
following addition of either CaCl2 (B and F), Na2HPO4 (C and G), or a
combination of both (D and H) to the indicated serum, were submitted
to micron-Raman spectroscopy. NB cultured from 10% healthy HS in
DMEM (I) and the NB strain ‘‘nanons’’ cultured in 10% FBS (J) were also
included for comparison. The various serum granulation/pellet and NB
specimens showed marked variability of peaks with phosphate ions
being obtained more consistently. Phosphate peaks were seen at
361 cm
21, 440 cm
21, 581 cm
21, 962 cm
21, 1,002 cm
21 (HPO4
22), and
1,048 cm
21 whereas carbonate peaks were noticed at 280 cm
21,
712 cm
21, 1,080 cm
21, and 1,150 cm
21. Commercially available CaCO3
(K), Ca3(PO4)2 (L), and HAP (M) were included for comparison.
doi:10.1371/journal.pone.0005421.g009
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phosphate (Fig. 6C, HS-4). Other experiments revealed a gradual
transition to HAP, from the acquisition of a monocalcium
phosphate complex (Fig. 6D, FBS-2) all the way to the formation
of a final Ca10 HAP crystal, as indicated by the prominent peak at
31.8 degrees on the 2-h scale (Fig. 6E, FBS-4). HAP crystals could
be detected at times even when the initial serum pellets were
obtained from untreated serum samples, as illustrated by Figure 6F,
where a small Ca10 HAP signal could be seen against the
amorphous background. The presence of both amorphous and
crystalline forms of calcium phosphate in the same samples
confirms the earlier morphological findings of a wide progression
of forms spanning from small round particles all the way to films.
These XRD spectra were similar to those seen for NB cultured
from 10% HS (Fig. 6G, HS-NB) or from 10% FBS (Fig 6H, shown
here for the NB strain ‘‘nanons’’) which both gave spectra that
overlapped entirely with the Ca10 HAP peak seen at 31.8 degrees,
as also seen with the commercially available powder used as a
reference (Fig 6I, HAP). Compared to the HAP control, however,
both our serum granulations and NB gave variable XRD spectra
yielding either amorphous patterns or a few single peaks,
indicating variable, if not lower, degrees of crystallinity (Fig. 6D–
F, compare these with the number and intensity of peaks seen for
the HAP control shown in Fig. 6I, which revealed a much more
complex pattern of peak signals). In the case of the serum
granulations, the intensity of these peaks could be modulated by
the amount of calcium and phosphate added to the serum as well
as by the temperature and length of the subsequent incubation,
with greater crystallinity resulting from higher amounts of
precipitating ions, longer incubations, and higher temperatures.
In the case of NB, the degree of crystallinity varied also with the
amount of serum added to the culture medium, with less
crystallinity being generally associated with higher amounts of
serum (5–10% compared to 1–2%; data not shown). This negative
correlation between crystallinity and serum protein content
appears to support the notion of a dual inhibitor-seeder role for
serum proteins proposed here to explain the formation of both
calcium granulations and NB from serum. Finally, it should be
Figure 10. Serum granulations and NB specimens show similar electron diffraction patterns. Serum granulations (pellets) obtained from
untreated serum (A and E) or following addition of either CaCl2 (B and F), Na2HPO4 (C and G), or a combination of both (D and H) to the indicated
serum, were processed for TEM without fixation or staining. NB cultured from 10% HS (I) as well as the NB strains ‘‘nanons’’ (J) and DSM 5820 (K)
cultured in 10% FBS were also included for comparison. The electron diffraction patterns shown in the insets indicated that the serum granulations
and the NB samples consisted of polycrystalline minerals either with a low degree of crystallinity as shown by the fuzzy rings (A, B, E–G) or with a
more crystalline mineral phase as shown by the presence of arrays of dots on the corresponding diffraction patterns (C, D, H). In comparison, the
commercial reagents CaCO3 (L), Ca3(PO4)2 (M), and HAP (N), used as controls, more consistently displayed a high degree of crystallinity as shown by
the presence of dots on their electron diffraction patterns. Scale bars: 50 nm (A, L); 100 nm (B–E, G, I, J); 200 nm (F, H, K, N); 500 nm (M).
doi:10.1371/journal.pone.0005421.g010
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granulations and NB; similar spectra have been described for
extra-skeletal calcification deposits associated with various human
diseases [38,42].
Next, energy-dispersive X-ray spectroscopy (EDX) was done on
the same serum pellets obtained from either control serum or from
serum treated with calcium, phosphate, or both. As revealed by
EDX analysis, untreated serum pellets contained various elements,
including calcium and phosphorus (Fig. 7E, compare signals with
thoseobtained forthe CaCO3,Ca 3(PO4)2,andHAPcontrolsshown
in Fig. 7L–N) and, at times, unrelated metallic elements (Fig. 7A,
with a FBS-1 sample showing the presence of titanium). Upon
addition of precipitating ions, the resultant mineral complexes
formed by any one of the ion treatments accumulated calcium and
phosphorus with Ca/P ratios typicallyreaching between 1.2and 1.9
(Fig. 7B–D, F–H), again indicating heterogeneity of calcium
phosphatecompositions,spanning probablyfrommono-basicforms
all the way to crystalline apatite. Thus, even the treatment of serum
with either calcium or phosphate alone resulted in the formation of
serum granulations that contained both calcium and phosphorus,
attesting to the high binding affinity between calcium and
phosphate and consequently their preferential co-precipitation as
mineral particles. In the case of serum pellets prepared following
serum treatment with calcium alone, the presence of phosphorus
gradually increased on EDX spectra as a function of the time of
incubation. For instance, a serum pellet obtained after addition of
calcium to FBS followed by a short incubation period of 1 hour
showed only a small incorporation of phosphorus (Fig. 7O, labeled
asFBS-29;note the lowphosphorus peak),butafterlongerovernight
incubation, the amount of phosphorus incorporated into the serum
pellet was considerably increased (Fig. 7P, labeled FBS-20), which
now appeared indistinguishable from that seen associated with the
other spectra shown earlier. These observations further support the
notion that amorphous calcium compounds formed in the absence
of phosphorus tend to acquire phosphorus when further exposed to
phosphate-containing medium, a process that is expected to
continue until HAP is formed, due to the high binding affinities
known to exist between calcium and phosphate [13,16].
Beside calcium and phosphorus, other elements were also
detected but these varied with the lots of serum used and did not
appear to be representative (Fig. 7A–F, and H). The Ca/P ratios
observed for the serum granulations studied here fell within the
range described earlier for NB as well as for carbonate HAP
associated with bones [2,13]. Thus, serum granulations were
shown to have elemental compositions similar to NB derived from
HS (Fig. 7I, with the NB specimen obtained from a culture of
DMEM inoculated with 10% HS derived from a healthy donor).
Similar EDX profiles were also obtained for NB cultured from
10% FBS, as exemplified by the two representative EDX analyses
obtained for the NB strains ‘‘nanons’’ (Fig. 7J) and DSM 5820
(Fig. 7K). All NB samples displayed major peaks of calcium and
phosphorus similar to those seen for the serum granulations.
Again, the EDX profiles presented here are not unique to our
serum granulations or NB as similar profiles have been associated
with calcium granules found in platelets [43] as well as in ectopic
pathological calcifications [44]. In all these specimens examined,
there was a predominance of calcium and phosphate peaks as
revealed by EDX.
The mineral phase associated with NB has been identified
earlier as carbonate HAP [1,2] which is also the mineral found in
bones [45,46]. In our serum granulation samples, a peak at
31.8 degrees on the 2-h scale, as seen on the XRD spectra and
attributed to Ca10 HAP, was the main signal detected (Fig. 6E and
F). The presence of carbonate in our samples would call mainly for
an overlapping signal near 33 degrees on the same 2-h scale, but
this peak is difficult to distinguish from the HAP signal seen near
this region [13]. Furthermore, it is not clear whether our samples
carry this particular crystalline diffraction plane for carbonate. To
verify whether carbonate is indeed present in the serum
granulations, Fourier-transformed infrared spectroscopy (FTIR)
was used instead. FTIR is known to yield more distinct carbonate
and phosphate signals; it also allows for the presence of related
amorphous groups to be better distinguished.
Serum granulations obtained from untreated serum or from
serum treated with additions of either calcium, phosphate, or both,
gave peaks corresponding to carbonate groups as well as
phosphate moieties (Fig. 8A–H). Peaks corresponding to carbonate
groups could be seen at 875 cm
21 and around 1,400–1,430 cm
21,
with a noticeable split in the asymmetric stretching band seen in
this latter position (Fig. 8A–H, compare with the spectrum of
CaCO3 shown in Fig. 8K; see also refs. 47 and 48) while
phosphate absorption peaks were noticed at 575 cm
21, 605 cm
21,
960 cm
21, and 1,000–1,150 cm
21 (Fig. 8A–H, compare with
signals obtained for Ca3(PO4)2 and HAP shown in Fig. 8L and M,
respectively; see also refs. 49 and 50). Although there was some
variability in the signal strengths seen with the serum samples, with
some producing low or barely detectable signal strengths, there
was generally the presence of both carbonate and phosphate peaks
in all the serum pellet samples seen.
While all FBS and HS samples, including untreated controls,
produced granulations that yielded small or barely detectable
signals at 875 cm
21, they gave much stronger signals at the 1,400–
1,430 cm
21 position, indicating the clear presence of amorphous
carbonate in these preparations. Compared to the carbonate
signals, the phosphate signals were more prominent in all the
serum pellets. In the case of untreated FBS granulations, the peak
corresponding to carbonate groups at 875 cm
21 was absent
(Fig. 8A), but the presence of carbonate in this sample was
apparent from the other carbonate peak at 1,400 cm
21 (Fig. 8A).
The intensity of the phosphate absorption bands in untreated FBS
pellet was also low (Fig. 8A, compare the intensity of the
phosphate bands at 575 cm
21, 605 cm
21, 960 cm
21, and
1,000–1,150 cm
21 with those of the other serum pellets in
Fig. 8B–H). While these observations would suggest that only a
low amount of carbonate and phosphate might be present in the
untreated FBS pellet seen here, it should be noted however that
there was considerable data variability depending on the serum lot
used. The untreated HS-1 pellet for example produced much
stronger carbonate and phosphate signals when compared with its
untreated FBS-1 counterpart (Fig. 8E, compare with Fig. 8A). The
variability seen with the spectroscopy patterns, especially the ones
associated with serum granulations derived from untreated serum,
suggests in a certain degree of chemical heterogeneity, a scenario
which would parallel the marked morphological heterogeneity
seen earlier.
Other peaks corresponding to amide I, II, and III, were noticed
for the various serum granulations at 1,660 cm
21, 1,550 cm
21,
and 1,250 cm
21, respectively (Fig. 8A–H; see refs. 45 and 51).
These peaks correspond to the different modes of absorption of the
amide bond commonly found in proteins. For instance, the peak of
amide I is principally attributed to the stretching vibration of the
C=O bond, while the peak of amide II represents the bending of
the planar N-H bond as well as the stretching vibration of the C-N
bond [51]. Finally, the peak of amide III also corresponds to the
bending of the N-H bond [51]. The presence of these different
absorption components of the amide bond indicates that proteins
are abundantly present in the serum granulations. It should be
noted however that the peak corresponding to amide I at
Calcium Granulations in Serum
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21 could not be distinguished clearly from an overlap-
ping peak at 1,650 cm
21 attributed to the presence of the hydroxyl
group or residual water [52,53] (Fig. 8K–M; note the presence of
the peak corresponding to the hydroxyl group or residual water at
1,650 cm
21 in the controls which would unlikely contain any
proteins). The amide III peak on the other hand overlapped with
the broad phosphate group seen on its right (Fig. 8E). In contrast,
the amide II peak at 1,550 cm
21 appeared unique and was clearly
seen in all the serum pellet samples (Fig. 8A–H).
The FTIR spectra obtained for serum granulations were next
compared to those obtained for NB cultured from 10% HS (Fig. 8I)
or for ‘‘nanons’’ cultured in 10% FBS (Fig. 8J). Both serum
granulations and NB showed the presence of small carbonate and
phosphate peaks at the exact same positions. The peak
corresponding to amide I at 1,660 cm
21 was also noticed in the
NB specimens, but the amide II peak at 1,550 cm
21 and the
amide III peak at 1,250 cm
21 were absent (Fig. 8I and J). These
results indicate that the NB specimens studied here may contain
significantly less protein than the serum granulation samples,
consistent with the fact that these serum granulations had been
obtained directly from whole serum while the NB preparations
were obtained from DMEM containing only 10% serum, not to
mention their prolonged incubation in culture that may have
resulted in the progressive degradation of proteins as suggested by
our previous study [13]. From this simple comparison, however, it
can be inferred that, while serum granulations and NB may differ
somewhat in protein content, they appear to have a similar
chemical composition insofar as carbonate and phosphate groups
are concerned. In this respect, the FTIR data shown here for both
serum granulations and NB resemble those collected earlier for
calcium granules found in vivo within kidney or pancreatic tissues,
which also revealed the presence of carbonate and phosphate
suggestive of carbonate apatite [54–56].
We also verified the chemical composition of the same serum
granulations by micro-Raman spectroscopy analysis. Depending
on the serum lot used, serum granulations prepared from FBS and
HS gave marked variability in the nature of the peaks seen
(Fig. 9A–H). For instance, the spectra of the FBS granulations
obtained from untreated serum did not show any substantial peak
(Fig. 9A) while the serum granulations obtained following the
addition of either calcium or phosphate, or both, showed low
broad peaks at 962 cm
21 characteristic of phosphate ions while
the signals for carbonate could not be detected in these same
samples (Fig. 9B–D). These results stood in marked contrast to the
spectra obtained for control commercial preparations of calcium
carbonate as well as the calcium phosphate compounds Ca3(PO4)2
and HAP, as shown in Figure 9K–M [see also refs. 57 and 58].
Note that the calcium carbonate control yielded typical signals at
280 cm
21, 712 cm
21 and 1,080 cm
21 (Fig. 9K). As for the
phosphate signal, due to the low intensity of the signals observed
here, we could not discern the other phosphate ion peaks at
361 cm
21, 440 cm
21, 581 cm
21, 1,048 cm
21 and 1,076 cm
21
seen in our earlier NB preparations [13] as well as in the
Ca3(PO4)2 and HAP controls (Fig. 9L and M, respectively).
The spectra obtained for untreated HS granulations as well as
HS granulations obtained following additions of phosphate were
similar as judged by the presence of both phosphate and carbonate
peaks at 1,002 cm
21 and 1,150 cm
21, respectively (Fig. 9E and G,
with similar signals having been attributed respectively to HPO4
22
ions in ref. 58 and to CO3
22 substitutions in the HAP lattice in ref.
59). On the other hand, HS granulations obtained following
addition of calcium yielded a low peak of carbonate near
1,080 cm
21 whereas the phosphate signals were either absent or
barely visible (Fig. 9F; compare with the spectrum of CaCO3
shown in Fig. 9K). Finally, following the addition of both calcium
and phosphate to HS, the granulations obtained gave low peaks
corresponding to phosphate at 440 cm
21 and 962 cm
21 as well as
a low peak of carbonate at 1,080 cm
21 (Fig. 9H). It should be
noted that some peaks of low intensity seen for example at
1,002 cm
21 and 1,150 cm
21 in HS serum granulations (Fig. 9E
and G) were not observed in commercial control preparations
(Fig. 9K–M). Similarly, some peaks present at 290 cm
21,
361 cm
21, 702 cm
21, and 1,048 cm
21 in the commercial
powders included as references, annotated in Figure 9K–M in
accordance with refs. 57, 58, 60 and 61, were rarely seen in our
samples. Although phosphate and carbonate peaks were obtained
consistently for serum granulations when subjected to the FTIR
analysis, it is speculated that the absence of noticeable carbonate
and phosphate peaks in some of the Raman spectra may be due to
the overwhelming presence of proteins in the serum granulation
samples, a notion consistent with published studies [45].
Accordingly, under the influence of the green laser used for the
Raman analysis, proteins produce fluorescence which results in the
presence of a high background with concomitant dampening of
the signal-to-noise ratios related to the specimens [45].
In support of this explanation, the spectra of NB samples
cultured from 10% HS (Fig. 9I) or 10% FBS (Fig. 9J) consistently
showed peaks of phosphate at 440 cm
21, 581 cm
21, and
962 cm
21 as well as carbonate peaks at 1,080 cm
21 that were
slightly more noticeable than those produced by serum granula-
tions, perhaps due to a lower protein content associated with NB
as compared with serum granulations. In spite of these intensity
differences, the positions of the various peaks seen with NB and
serum granulation samples appeared virtually indistinguishable.
Together with the data obtained through EDX and FTIR
analyses, our Raman data further support the notion that the
serum granulations and NB have a similar chemical composition.
Similar Raman profiles have also been seen earlier in
association with various calcification deposits in humans as in
the case of atherosclerosis, which also gave similar signals for
carbonate and phosphate groups [62,63]. These observations
suggest that the calcium deposits found in vivo share many of the
morphological and chemical characteristics of serum granulations
and NB described here.
We examined further the crystalline nature of serum granula-
tions by analyzing their electron diffraction patterns obtained by
TEM (Fig. 10, insets). Along with the TEM images of serum
granulations shown in Fig. 4, the additional images shown in
Figure 10 illustrate the marked morphological heterogeneity seen
associated with serum granulations (compare Fig. 10 with Fig. 4;
note also the typically crystalline morphology of the control
commercial preparations of CaCO3,C a 3(PO4)2, and HAP now
included as controls in Fig. 10L–N, respectively). Both Figures 4
and 10 reveal pleomorphism within the same sample preparations.
For instance, the same untreated control FBS-1 sample was shown
to harbor both amorphous aggregate shapes (Fig. 4A) as well as
round electron-dense particles (Fig. 10A). Likewise, HS-1 obtained
from untreated control serum was also seen to contain both
granular aggregates (Fig. 10E) and more crystalline spindles
(Fig. 4E). Others like HS-2 showed round particles (Fig. 4F)
undergoing progressive stages of aggregation and fusion (Fig. 10F).
As can be seen from the diffraction patterns presented in the
insets of Figure 10, most serum pellet samples displayed several
fuzzy concentric rings of variable intensities characteristic of
polycrystalline materials with low degrees of crystallinity (Fig. 10A,
B, E–G) while others produced more intense rings with dots
indicating a higher degree of crystallinity (Fig. 10C, D, and H).
The presence of dots in the diffraction patterns of some serum
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crystalline particles similar to the secondary CPP seen elsewhere
[40], but occasionally even such particles produced patterns with
concentric rings without visible dots (Fig. 10B). The fuzzy
concentric pattern was independent of the source of serum or
the type of serum treatment used. By comparison, the diffraction
patterns obtained for the commercial controls consistently showed
the presence of discrete arrays of dots (Fig. 10L–N). Such dots
indicate a higher intensity of diffraction obtained at specific angles
and are usually seen in crystals with a high degree of crystallinity.
From this comparison, it appears that the serum granulation
samples studied here consisted of polycrystalline materials with
relatively low degrees of crystallinity which may be attributed in
turn to the presence of amorphous mineral phases undergoing
varying degrees of crystallization, as demonstrated by several
samples submitted to XRD analysis (Fig. 6A–C). On the other
hand, the low crystallinity may also correspond to the presence of
carbonate substitutions in the crystal lattice [49]. Diffraction
patterns with similar fuzzy concentric rings were also observed in
dentin [64] and calcified cartilage [65], as well as in tissues
undergoing extraskeletal calcification [66], which were also
interpreted as the presence of HAP possessing a low degree of
crystallinity. As a further reference, diffraction patterns of the
mineral precursor in bones produced amorphous diffraction
patterns while more mature bone harbored both fuzzy rings and
dots similar to the more crystalline patterns obtained for some of
our serum granulations [67]. This suggests that calcium granula-
tions found in the serum resemble closely calcium phosphate
deposits found in the human body in both normal and
pathological conditions.
Identification of proteins associated with serum-derived
calcium and apatite granulations
By SDS-PAGE analysis, the protein profiles associated with
serum granulations consisted of three main bands (Fig. 11). Lanes
1 through 10 of Figure 11A, shown for FBS granulations,
represent the exact SDS-PAGE profile counterpart of Figure 1.
No protein band was seen in the untreated FBS pellet (Fig. 11A,
lane 1). Increasing the amount of calcium (lanes 2–5) or phosphate
(lanes 6–8) or calcium and phosphate (lanes 9 and 10) produced a
dose-dependent increase in the intensities of protein bands
associated with the granulations. Three major bands of 66–
75 kDa, 52–65 kDa, and 27–33 kDa were seen with the
granulations obtained from both FBS (Fig. 11A) and HS
(Fig. 11B), similar to what had been seen earlier with serum NB
[13,15]. The three major bovine proteins were identified by
MALDI-TOF mass spectrometry as albumin (3 out of 3 trials),
fetuin-A (1/10), and apolipoprotein A1 (2/3), matching exactly
with the NB proteins identified earlier through SDS-PAGE [13].
As shown before for FBS-NB [13], and in contrast to another
published study [15], fetuin-A did not represent a major protein
species even though fetuin-A is one of the more abundant proteins
in FBS and represents one of the most avid binders of apatite [see
refs. 35 and 68 for excellent reviews on fetuin-A]. Instead, several
other proteins were also identified in the same fetuin-A position:
coagulation factor X (3/10), cytoplasmic actin 1 (2/10), cytoplas-
mic actin 2 (1/10), myotubularin-related protein 9 (1/10),
adenosylhomocysteinase (1/10), and tubulin b-2C chain (1/10).
Multiple proteins were also found in the other band positions.
Thus, for the 27–33 kDa band, flotillin-1 (1/3) was also identified
in addition to bovine apolipoprotein A1.
Figure 11. SDS-PAGE profiles of proteins bound to serum granulations and protein identification. (A) Serum granulations (pellets) were
prepared exactly as in Fig. 1, from either untreated FBS (referred as ‘‘None’’) or through the addition of the indicated amounts of CaCl2 (‘‘Calcium’’)
and/or Na2HPO4 (‘‘Phosphate’’) to FBS. The indicated sequence of the lanes depicted in the heading matches exactly with the sequence of wells seen
in Fig. 1. No protein band was found in the pellet of untreated FBS (lane 1), whereas the other lanes showed dose-dependence with respect to the
precipitating reagents used. The white marks represent the positions of the bands excised for identification by MALDI-TOF mass fingerprint analysis
whereas the identified proteins are shown on the right. While bovine serum albumin (BSA) and apolipoprotein A1 (b Apo-A1) were the only proteins
identified in their respective positions, other proteins besides bovine fetuin-A (BSF) were also identified in the 52–65 kDa range (see the text for
details). (B) This HS pellet was obtained with 30 mM CaCl2 and processed exactly as done with the FBS pellets. Abbreviations used: HSA, human
serum albumin; HSF, human serum fetuin-A; and h Apo-A1, human apolipoprotein A1.
doi:10.1371/journal.pone.0005421.g011
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apolipoprotein A1 (1/1) were also identified as indicated in
Figure 11B, with the three proteins labeled as HSA, HSF, and h
Apo-A1, respectively. These three proteins were also seen as the
main protein bands associated with HS-NB [13]. From the gel
profile displayed in Figure 11B, it can be seen that while albumin
and apolipoprotein A1 represent indeed the major protein bands
visible by Coomassie blue staining, the fetuin-A (HSF) band was
much less visible. This observation is again consistent with the
findings made earlier with HS-NB [13].
In that earlier study [13], we found that several large molecular
weight proteins were not dissolved by our gel sample buffer
containing EDTA, SDS, and reducing agents and thus these same
proteins were found not to migrate into the resolving protein gel.
To circumvent this issue, we used a two-step procedure of in-
solution-trypsin digestion followed by reversed-phase high perfor-
mance liquid chromatography (HPLC) to identify the serum
pellet-bound proteins, obviating the need to subject the mineral-
bound proteins first to SDS-PAGE [13]. Using this approach, we
were able to obtain a more extensive determination of the proteins
associated with serum granulations. This approach also allowed us
to identify several additional high molecular weight proteins that
could not be seen on the gel electrophoresis presented in Figure 11.
The main proteins obtained using this alternative proteomic
approach are displayed in Tables 1 and 2. Table 1 shows the
protein data for FBS granulations and FBS-derived NB while
Table 2 displays the proteins obtained for HS granulations and
HS-derived NB. In order to have a qualitative indication of the
relative abundance of each protein within a sample [69], the
amount of unique peptides obtained for each protein was first
divided by the total amount of unique peptides obtained for the
first 50 proteins in the sample; the number 50 was decided
arbitrarily for purposes of standardized normalization and
comparison. The value obtained was then multiplied by 100 to
obtain a relative value reflecting the abundance of each protein.
The order of the proteins presented was based on the sum of the
values obtained for each protein identified for all four FBS
granulations as well as the four types of FBS-NB used, and the
total value derived was in turn used to produce the ranking
sequence seen in Table 1 (shown here for only 12 proteins). In the
case of human samples, this same sequence was based on the
summation of frequency values obtained for the 4 HS granulations
and the HS-NB sample used (Table 2). The order of proteins
shown in both Tables 1 and 2 stood in general agreement with the
relative abundance of each protein studied within any given
sample, but there were exceptions to this rule. For example, in
Table 1, prothrombin in the FBS-4 sample was more abundant
than complement component 3, whereas in the other three FBS
granulations, this order was reversed. It is also possible that using
this methodology some large proteins may have scored higher than
other smaller proteins due to their containing likely more trypsin
cleavage sites and consequently generating more associated
peptides that may have skewed the ranking frequency in their
favor. Nonetheless, the relative abundance derived here provides a
useful reference regarding the relative distribution of the proteins
found in the various serum granulation samples.
As seen in Table 1, the protein composition of the different FBS
granulations was similar, with albumin (ranked the most abundant
protein), fetuin-A (ranked 4
th), and apolipoprotein A1 (5
th)
representing among the five main proteins identified in each case.
The presence and relative abundance of these three proteins are in
agreement with the protein gel profiles presented earlier (Fig. 11).
However, in addition to these three proteins, complement
component 3 (ranked 2
nd) and prothrombin (3
rd), were also
identified that were not obvious from the SDS-PAGE analysis. In
other words, with its relative abundance, complement component
3 should have appeared as a noticeable band of 187 kDa in the
SDS-polyacrylamide gel while prothrombin (71 kDa) should have
been detected in the albumin region after gel excision and protein
determination, but as seen from Figure 11, this was not the case
Table 1. Proteins of FBS serum granulations and nanobacteria identified by MALDI-TOF mass spectrometry.
# Identified Proteinsa MWb (kDa) Serum Granulations
c Nanobacteria
d
FBS-1 FBS-2 FBS-3 FBS-4 FBS NB Nanons DSM 5820 DSM 5821
1 Serum albumin 69 15 11 12 10 27 11 9 17
2 Complement component 3 187 11 6 10 5 13 6 6 5
3 P r o t h r o m b i n 7 1 35592 88 6
4 Fetuin-A 38 54445 56 6
5 A p o l i p o p r o t e i n A 1 3 0 54338 34 6
6 Coagulation factor V 249 45730 54 3
7 Hemoglobin fetal subunit b 1 6 63435 46 5
8 Vitamin K-dependent protein S 75 44170 67 1
9 Thrombospondin-1 130 63540 60 0
10 a-1-antiproteinase 46 64425 40 2
11 Hemoglobin subunit a 1 5 22113 22 1
12 Adiponectin 26 02110 10 0
aThe values shown for each protein correspond to the number of unique peptides identified for each protein which was divided by the total number of peptides
obtained for the first 50 proteins obtained in one sample. This value was then multiplied by 100 to reflect the relative abundance of each protein (see the text for more
details).
bMW: molecular weight.
cSerum granulations (pellets) were obtained from untreated FBS (FBS-1) or following addition of either CaCl2 (FBS-2), Na2HPO4 (FBS-3), or both (FBS-4) as described in
the Materials and Methods.
dThe different NB samples presented here were all obtained from FBS as described in the Materials and Methods.
doi:10.1371/journal.pone.0005421.t001
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weights ranging between 15 kDa to 249 kDa) were likewise
identified but had not been detected by SDS-PAGE. At this time,
it is not clear whether the discrepancy seen between the two
protein identification methodologies can be explained by the
possibility that some proteins may have remained strongly bound
to the apatite particles, precluding them from being released into
the gel sample buffer in spite of harsh treatment with excess ionic
detergents and EDTA as well as boiling. From the data shown
here, however, it can be seen that calcium granulations obtained
from control, untreated serum (FBS-1) are virtually identical to
those collected following treatment of serum with excess calcium
(FBS-2) or phosphate (FBS-3), or a combination of both (FBS-4).
Albumin, complement component 3, prothrombin, fetuin-A,
and apolipoprotein A1 also appeared among the main proteins
obtained for FBS-NB (Table 1). The protein composition of NB
obtained from the slow culturing of DMEM inoculated with 10%
FBS was remarkably similar to that of the three strains of NB
used). These in turn were virtually indistinguishable from
granulations obtained from either untreated serum or serum
treated with excess calcium, phosphate, or both, indicating similar
biochemical compositions for all of them (compare the various
protein abundance values seen in Table 1). This finding is
significant since the NB specimens studied here appeared to have
less protein content when compared with our serum granulations,
as suggested by the FTIR analysis shown in Figure 8. That serum
granulations and NB should have similar, if not identical, protein
compositions as revealed by two different proteomic techniques
used here would indicate more of a quantitative rather than
qualitative difference associated with the various calcium granu-
lation and NB specimens.
For HS granulations, the three proteins albumin, complement
component 3 and apolipoprotein A1 were also among the more
abundant proteins identified (Table 2). However, apolipoprotein
B100 and complement component 4A were also identified as two
of the more commonly associated proteins (Table 2). In contrast,
fetuin-A and prothrombin were found at much lower frequencies
in the HS granulation samples as compared with the FBS
granulations (prothrombin ranked 27
th among proteins found in
HS granulations and therefore was not listed in Table 2). As seen
with FBS granulations, the serum granulations obtained from
control, untreated HS displayed a protein composition that was
virtually identical to that of the various granulations obtained from
HS after loading with calcium (HS-2), phosphate (HS-3), or both
(HS-4), indicating again that chemically identical granulations are
found in normal serum, albeit at much lower amounts, and that
the formation of these entities becomes magnified when the serum
becomes loaded with calcium and/or phosphate.
The various HS granulation samples were next compared to the
NB cultured from DMEM inoculated with 10% HS (Table 2).
With the exception of a2-macroglobulin, which turned out to be
among the three most abundant proteins for human NB, all other
proteins appeared to follow the same frequency pattern shown for
HS granulations (Table 2), indicating once again that the HS
granulations and NB seen here are probably identical entities.
In addition to the high molecular weight proteins identified and
shown in Tables 1 and 2, several others were identified among the
50 most abundant proteins: apolipoprotein(a) (501 kDa; HS
granulations), fibronectin (257 kDa; FBS granulations), coagula-
tion factor V (249 kDa; FBS granulations). Several other smaller
calcium-binding proteins were also found to be associated with the
mineral phase, including vitronectin (54 kDa; HS granulations),
vitamin-D-binding protein (53 kDa; both FBS and HS granula-
tions), and kininogen-1 (48 kDa; HS granulations). These proteins
were identical to the ones found associated with NB obtained from
cell cultures [13]. The results presented here overlap somewhat
with earlier studies done to identify the proteins bound to the bone
mineral. In one particular study using a similar proteomic
approach, the most abundant proteins of bovine bone extracts
found to bind the mineral phase of a HAP column also turned out
to be albumin and fetuin-A [70]. In fact, albumin has been found
at a concentration of 0.7 mg/g of bone in bovines [71] whereas
Table 2. Proteins of HS serum granulations and nanobacteria identified by MALDI-TOF mass spectrometry.
# Identified Proteinsa MWb (kDa) Serum Granulations
c Nanobacteria
d
HS-1 HS-2 HS-3 HS-4 HS NB
1 Complement component 3 187 8 10 8 15 12
2 Serum albumin 69 11 8 5 6 14
3 Apolipoprotein B100 516 8 6 11 8 6
4 Complement component 4A 193 7 4 4 7 6
5 Apolipoprotein A1 31 2 8 6 5 4
6 a2-macroglobulin 163 3 4 5 1 10
7 IGHM protein 53 3 2 2 1 2
8 Serotransferrin 77 3 0 0 0 4
9 Apolipoprotein A2 11 1 2 1 1 1
10 Haptoglobin 47 1 2 2 0 0
11 Fetuin-A 39 0 1 1 1 1
12 Hemoglobin subunit b 1 6 10000
aThe numbers shown for each protein correspond to the amount of distinct peptides obtained for each protein which was divided by the total amount of distinct
peptides identified in the first 50 proteins found in each sample. This value was then multiplied by 100 to give an indication of the relative abundance of each protein.
bMW: molecular weight.
cSerum granulations (pellets) were obtained from untreated HS (HS-1) or following addition of either CaCl2 (HS-2), Na2HPO4 (HS-3), or both (HS-4) as described in the
Materials and Methods.
dHS NB was obtained from human serum as described in the Materials and Methods.
doi:10.1371/journal.pone.0005421.t002
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bone in rats [72], bovines [71], and humans [73]. In addition,
several proteins present in the bones such as decorin, biglycan,
osteoadherin, and osteonectin were also identified by the use of a
proteomic approach similar to what we have done here [70].
The protein profile obtained for the Nanobacterium sp. strain
‘‘nanons’’ deserves some mention. As can be seen from Table 1,
‘‘nanons’’ contained a number of proteins and not just the two
proteins fetuin-A and apolipoprotein A1 described by Raoult et al.
[15]. This difference in results could very well be accounted by the
different techniques used. Like Raoult et al. [15], we have also
found that a limited number of bands (in our case, three main
protein bands) is seen by SDS-PAGE while multiple proteins can
be identified using the direct trypsin-digestion method outlined
here. Using both this alternative methodology as well as SDS-
PAGE, we have found however that the protein albumin was more
commonly observed than fetuin-A. This conclusion is apparent
from the data collected from all our serum granulation samples as
well as from the other NB specimens studied, including the two
strains DSM 5820 and 5821 (Table 1). This same conclusion is
further supported by the finding that fetuin-A represents one of the
less abundant proteins found associated with human NB and HS
granulations (Table 2). In retrospect, this is not surprising given the
fact that fetuin-A is found in the adult human serum at levels that
are at least 14–26 times lower than those found in FBS (0.7–
0.8 mg/ml in HS vs. 10–21 mg/ml in FBS, according to refs. 74
and 75). On the other hand, albumin is known to be present at
concentrations as high as 35–45 mg/ml in HS [76] and 23 mg/ml
in FBS [77], explaining its predominance in the composition of the
serum granulations obtained. Thus, the relative distribution of
proteins in the serum granulation scaffold appears entirely
circumstantial, a notion that we have proposed also for NB [13].
The presence of various apolipoproteins associated with serum
granulations is also noteworthy. Apolipoprotein A1, a protein
constituent of high-density lipoproteins (HDL) [78], was abun-
dantly found in the granulations obtained from both adult human
serum and FBS. On the other hand, apolipoprotein B100, a well-
known constituent of low-density lipoproteins or LDL [78], was
among the more common proteins found attached to the human
serum granulations. Other apolipoproteins obtained include
apolipoprotein A2 (11 kDa, HS granulations) and apolipopro-
tein(a) (501 kDa, HS granulations) which are found in HDL and
lipoprotein Lp(a) particles, respectively [78]. At this time, it is not
clear whether the association of serum granulations with the
various apolipoproteins is also circumstantial, reflecting merely
their relative abundance in the serum, or whether there is a
selective enrichment for the apolipoprotein family of proteins in
both serum granulations and NB [see also ref. 13]. Given the
observations that serum lipids bind to these same particles and that
several phospholipids have been shown to nucleate apatite
formation [14,79], it is also possible that circulating lipoproteins
in our serum samples may very well anchor apatite, perhaps
accounting for at least some of the apatite-seeding activity seen
here. In support of this possibility, granulations obtained from
untreated serum (both HS and FBS) were seen to be quite
heterogeneous, as exemplified through the various ultramicro-
scopic images shown. More studies will be needed to assess the role
of lipoprotein particles in the formation of the serum granulations
described here.
Functional involvement of proteins in both inhibition
and seeding of serum granulations
The identification of a number of discrete proteins associated
with both FBS and HS granulations prompted the question of
whether similar circulating serum proteins may play a functional
role in keeping calcium and phosphate soluble in the serum under
normal, untreated conditions. To address this question, both FBS
and HS samples were treated with 0.5% trypsin, after which the
trypsin-treated serum was incubated for either 2 hours or
overnight at 37uC, followed by centrifugation exactly as before
at 16,0006g. After 2 hours of incubation, little or no pellet could
be discerned, but with longer overnight incubations, small pellets
appeared with both trypsin-treated FBS and HS. Upon inocula-
tion of these pellets into serum-free DMEM, it could be seen that
the pellets obtained from an overnight trypsin-treatment produced
particle seeding following incubation, as evidenced by the clouding
of the medium seen both visually and by A650 reading (Fig. 12A,
‘‘Day 4’’ panel, wells 3). This seeding effect was more noticeable
with the FBS pellet compared to the HS pellet (Fig. 12A, ‘‘Day 4’’
panel, wells 3; compare the amount of pellet and A650 reading for
these 2 samples). The same particle-seeding effect was time-
dependent and increased over a course of several days, ruling out
the possibility that the initial pellet could have accounted for the
turbidity readings (compare the various panels examined on ‘‘Day
4’’ and ‘‘Day 8’’ with the panel labeled as ‘‘Day 1’’ referring to the
first day of pellet collection and seeding). In contrast, neither
control DMEM (Fig. 12A, wells 1) nor untreated control serum
(Fig. 12A, wells 4 and 5) produced any significant increase in
turbidity under these conditions. When analyzed by SDS-PAGE,
the trypsin-treated pellets did not produce any visible protein
band, but, morphologically, the granulations produced under
these conditions were virtually indistinguishable from those seen
without trypsin treatment (data not shown). Thus, a variety of
shapes that included round particles, spindles, and even films, were
seen associated with these pellets (not shown).
A similar precipitation and particle-seeding effect was observed
with chymotrypsin (Fig. 12B; compare the amount of pellet and
A650 readings of the ‘‘Day 4’’ panel, wells 3, with the equivalent
wells seen in the ‘‘Day 1’’ panel, obtained on the day of pellet
inoculation). In our hands and compared to trypsin, chymotrypsin
was less effective in producing serum pellets, with the incubation
done under identical conditions. As expected, the amount of
subsequent particle seeding produced by serum granulations
obtained after chymotrypsin treatment was also significantly lower
(compare the wells in column 3 of the ‘‘Day 4’’ and ‘‘Day 8’’
panels in Fig. 12B with their equivalents in Fig. 12A). However, as
in the case of the trypsin experiment, the turbidity seen with the
chymotrypsin treatment also increased progressively with the
length of incubation, indicating an active seeding effect that
resulted probably from cumulative nucleation and growth of HAP
(Fig. 12B).
These results indicate that protease-sensitive protein moieties
appear to contribute to the maintenance of calcium and phosphate
solubility in the serum. That is, protease treatment of both FBS
and HS alone resulted in precipitation, a result that became more
pronounced when the serum incubation with the protease was
lengthened from 2 hours to overnight. The pellets obtained under
these conditions were then further shown to have particle-seeding
or proliferation activity upon subsequent inoculation into fresh
medium. That the protease-treated serum should generate
insoluble precipitates is in line with earlier reports addressing the
role of major serum proteins like albumin [80] and other apatite-
binding proteins [81] in keeping both calcium and apatite in
solution in the serum. The protease experiments also demonstrate
that the serum precipitates obtained in the absence of these
proteins appear to resemble morphologically the serum granula-
tions formed in the presence of intact serum proteins (comparative
data not shown), suggesting that perhaps there are other organic
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may similarly modulate and create the same pleomorphic
granulation shapes.
It should also be noted that in a previous study [13], we had
shown that trypsin treatment of serum enhanced the production of
NB-like particles when the same serum was inoculated into fresh
medium. Based on our findings here, however, it can be inferred
that the treatment of serum with proteases results in the direct
precipitation of apatite complexes which in turn exert a particle-
seeding effect when transferred into fresh serum-free medium.
While our results do not address the role of any specific protein(s)
in this process of precipitation, our findings do point to a direct
chemical binding phenomenon involving both proteins and
minerals that may form the basis for the dual inhibition and
seeding mechanisms deemed necessary for the assembly of the
calcium/apatite granulations studied here. Similar mechanisms
may also be involved in the assembly of entities that most likely
have become misconstrued as living microorganisms or as
calcifying agents of disease known as NB. More importantly, our
results also suggest that these same mechanisms may be widely
used in nature for the generation of similar calcium and apatite
granules.
Conclusion and future perspectives
The results shown here demonstrate that the protein scaffold and
its main constituents found associated with NB [13] can now be
reproduced directly with whole serum. That is, we are able to
reproduce here the NB phenomenology in its entirety using only
serum and without the need for the prolonged incubations in cell
culture medium previously deemed necessary for the growth and
demonstration of NB. The proteins identified here as part of serum
granulations also represent the more abundant serum proteins that
happentobindavidly toboth calciumandapatite[13].This protein
binding to calcium and apatite may represent a general mechanism
of protection deployed within the blood compartment and possibly
withinalltheotherbodyfluidsthatservestocopewithcalciumand/
or phosphate loading. In this sense, the calcium granulations seen
here can be viewed as by-products or remnants of calcium and
apatite binding reactions that may likely become amplified through
calcium and phosphate loading. Along this vein of reasoning,
perhaps the same pathways may also be amplified artificially in
culture mediums exposed to serum proteins and saturating levels of
calcium and phosphate, which may have given the erroneous past
impression of supporting the existence of exotic organisms or
perhaps novel pathogenic entities referred as NB [1–8].
Serum has long been known to contain potent inhibitors of
spontaneous calcium and apatite precipitation [82]. Serum
proteins mediating apatite inhibition include both calcium-binding
proteins like albumin and apatite-binding proteins like fetuin-A
[81]. In this respect, our previous study had shown a paradoxical
inhibitory effect of serum on NB formation that also turned out to
be trypsin-sensitive [13]. Preliminary results using the NB-like
precipitation system developed in that study [13] suggest that the
addition of excess calcium and/or phosphate to serum, even at the
high concentrations used, may not have exhausted the full
inhibitory (and seeding) capacity of the serum studied and that
only a fraction of the total inhibitory components has been
consumed during this process (not shown). The possibility also
exists that other calcium- and phosphate-binding factors, including
non-proteinaceous components, may be present in the serum in
large amounts and that these factors may remain soluble even in
the presence of excess calcium or phosphate. In fact, small
inorganic compounds like pyrophosphate have been shown to
inhibit effectively apatite formation [83,84]. The chemical
structure of pyrophosphate has led to the development of synthetic
calcification inhibitors like bisphosphonates [83,85], now used as
treatments for the prevention of mineral loss in osteoporosis [86].
It appears that the calcification inhibitory mechanisms seen in
the serum, as evidenced from our study here, are geared to
effectively bind both calcium and phosphate. When both calcium
and phosphate are present in the serum, the inhibitory complexes
appear to reach saturation with ion concentrations ranging
between 1 to 3 mM each, above which there is the formation of
precipitating complexes and granulations resembling the putative
NB. The range of ion concentrations that induces a transition from
solubility to precipitation may vary with the particular conditions
used, as exemplified by experiments using longer periods of
incubation from 1-to-7 days, whereby even calcium phosphate
concentrations under 1 mM could be shown to form NB-like
complexes (not shown). On the other hand, when either calcium or
phosphate is added individually to both FBS and HS, saturation is
not reached until much higher amounts of either ion species are
present, indicating that the inhibitory mechanisms inherent in the
serum can be effectively overcome only when both calcium and
phosphate are simultaneously present. Short of their dual
presence, it is more likely that a state of calcification-inhibition
would prevail instead.
The need for both calcium and phosphate to be present to
disarm this same calcification-inhibition reinforces the known
concept of ion-product (that is, calcium ion concentration6pho-
sphate ion concentration) used to determine the propensity for
calcification in any given fluid system [83]. Any solution at
physiological pH, ionic strength and body temperature, which
would include serum in body conditions, has been found to
spontaneously precipitate when its ion-product becomes equal to
or greater than 6610
26 M
2 [83]. This number is far above (in
fact, by at least 22 orders of magnitude) the chemical equilibrium
calculated from the solubility product of synthetic HAP as related
to its calcium and phosphate constituents. That is, calcium
phosphate has far greater propensity to nucleate HAP than what is
Figure 12. Trypsin and chymotrypsin treatment of FBS and HS generates pellets that have particle-seeding activity when
inoculated into serum-free medium. Seeding-pellets were prepared by adding trypsin (A) or chymotrypsin (B) at 0.5% to either FBS or HS,
followed by incubation at 37uC for 2 hours or overnight, then centrifugation and washing as described in the Materials and Methods.1 0ml aliquots of
these resuspended pellets (wells 2 and 3, with well 2 corresponding to 2 hours of serum incubation after protease treatment and well 3
corresponding to overnight incubation of the same protease treatment) were then inoculated into 1 ml of DMEM and incubated in cell culture
conditions for the time indicated on the left. ‘‘Day 1’’ refers to the day of pellet inoculation. As control, sera that received no addition of proteases
were also incubated, centrifuged, and washed the same way, after which the pellets (barely visible in most control specimens) were inoculated into
DMEM and incubated exactly as before (wells 4 and 5, described as ‘‘None’’). As an additional control, DMEM alone was incubated without any
inoculation (well 1). Note the time-dependent increase in turbidity associated with either protease treatment, more noticeable with the pellets that
had been obtained from sera treated with proteases overnight as contrasted with 2 hour treatment (compare between visuals obtained for wells 3
and 2). Turbidity was usually higher with the FBS pellets compared to HS pellets. Note also the different amounts of turbidity seen with trypsin (A) vs.
chymotrypsin (B) treatments; turbidities were generally higher with trypsin treatment. Control wells inoculated with pellets obtained from serum that
received no protease treatment (wells 4 and 5), or containing DMEM alone (well 1), produced either little or no visible turbidity.
doi:10.1371/journal.pone.0005421.g012
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serum inhibitors clearly removes this thermodynamically-favored
propensity toward calcification! Thus, with known HS concentra-
tions for calcium and phosphate averaging 1.2 mM and 1.3 mM,
respectively [83], the normal ion-product is 1.56610
26 M
2, still
below the ion-product threshold for calcification. However, the
ion-product concept cannot fully explain the different susceptibil-
ities of serum to precipitate in response to the various precipitating
ions added. Thus, our experiments demonstrate that while the
precipitation-threshold level of 6610
26 M
2 for the ion-product
can be exceeded by adding either calcium, phosphate, or a
combination of both, to give the same final ion-product, the
simultaneous addition of both calcium and phosphate is much
more effective in inducing HAP formation than the addition of
either calcium or phosphate alone. Accordingly, addition of
calcium alone to HS giving an ion-product that exceeds
6610
26 M
2 by as much as 30% has shown to produce little or
no precipitation. Along the same line of reasoning, phosphate is
more effective than calcium, when added to the same final ion-
product. Furthermore, precipitation occurs with the addition of
only 1 mM of both calcium and phosphate to serum that would
give in turn an ion-product of 5.06610
26 M
2, still below the
threshold level for precipitation, provided only that a prolonged
incubation is used. It can be inferred therefore that the
calcification-inhibitory processes inherent in the serum are geared
to dealing more efficiently with loadings of either calcium or
phosphate alone and are overcome much more easily with the
simultaneous presence of excess calcium and phosphate.
Given that the body fluids are supersaturated with respect to
calcium and phosphate ions [30–35], it can be surmised that the
same inhibitory factors and mechanisms must be at work to
maintain the solubility of these ions in the body fluids. It follows
that upsetting this balance, which would happen when the same
inhibitory state is finally overcome, should result in a likewise
precipitation of calcium phosphate and the formation of HAP,
which would then have to be disposed from the body in order for
calcification to be avoided. Since the blood levels of calcium and
phosphate are known to fluctuate even under normal conditions,
presumably the formation of a small amount of calcium phosphate
complexes can be expected to occur in the healthy state. These ion
fluctuations are probably more manifest locally in certain tissues
like the kidneys or the bones which experience a constant
remodeling process [83]. In a healthy state, these nascent mineral
complexes are likely to get removed from the serum by binding to
calcification inhibitors like fetuin-A and albumin, followed by
phagocytosis by the reticuloendothelial system (RES), or perhaps
via excretion in the urine [30,40,83]. Assuming that the inhibitory
system is overwhelmed as, say, in the case of cardiovascular or
late-stage kidney diseases, a more extensive deposition of calcium
phosphate complexes in the body may in principle contribute to
the disease process, and anomalous calcification has indeed been
seen in the disorders cited as examples here [87–89]. However, it
appears that the process of granule formation described here can
be explained by the workings of normal homeostatic mechanisms
that regulate calcium and apatite in the body and that seek to
prevent anomalous calcification.
Inthis context,the largenumberofproteinsbound tothe calcium
granulationsobtained frombothHSandFBS,alongwiththe earlier
spectroscopy data suggesting an abundant presence of bound
proteins, indicate that the apatite formation seen here corresponds
probably to a process of ‘‘heterogeneous nucleation’’—the forma-
tion of apatite crystals on a protein template [83]. While this term
has been used largely in the past to describe calcification seen
associated with collagen fibrils and other tissue- bound or
immobilized proteins as contrasted with spontaneous, ‘‘homoge-
nous nucleation’’ seen with calcium phosphate exceeding the
precipitation-thresholdlevelsforthe ion-product[83],itislikelythat
the apatite nucleation seen here involves a similar process of
heterogeneous nucleation since the same protein inhibitors that
bind to calcium or nascent calcium phosphate crystals may in fact
turn out to be the very anchors or seeds used for further apatite
growth once they undergo saturation and conformational change.
Finally, the resultant protein-mineral phase transformation is likely
to be temperature and time-dependent, which would be consistent
with the observations made here and elsewhere [13]. That is,
following binding to calcium or apatite and after undergoing the
necessary conformational change, the soluble calcification-inhibitor
presumably becomes insoluble,turning into a bona fidetemplate for
further apatite nucleation. That any calcium and apatite-binding
protein can act in principle as both inhibitor and nucleator of
apatite formation is actually supported by extensive studies done on
a numberof proteins with recognized roles inbiomineralization [see
the excellent review by Benesch et al., ref. 90]. Thus, in addition to
fetuin-A and albumin, proteins like amelogenin, decorin, bone
acidic glycoprotein 75, bone sialoprotein, chondrocalcin, fibrino-
gen, fibronectin, matrix G1a protein, osteocalcin, osteonectin,
osteopontin, statherin, vitronectin, and various other phosphopro-
teins have all been shown to display apatite inhibitory and/or
nucleating activities, with the predominance of one or the other
activity depending on both the in vitro or in vivo conditions used,
including whether the proteins were tested soluble or immobilized
on solid substrates [90].
The presence in the serum granulation and NB scaffold of
proteins like albumin, complement components 3 and 4A,
prothrombin, fetuin-A, apolipoproteins A1 and B100, as well as
other calcium and apatite binding proteins, appears to be entirely
circumstantial, depending on their availability in the serum milieu.
This conclusion is supported by the presence of select proteins in
the granule scaffold that depend solely on the particular species
and type of serum used (prothrombin in FBS granulations versus
apolipoprotein B100 in HS granulations; more of fetuin-A in FBS
granulations compared to HS granulations). That is, the protein
profile seen here reflects largely the relative abundance of these
same proteins in the serum used. Thus, albumin, the predominant
protein identified here, is not only one of the more abundant
serum proteins but is also known to account for about half of the
calcium-binding activity measured in HS [80]. Likewise, fetuin-A,
an avid apatite-binding protein, accounts for about half to one-
third of the total serum inhibition of the spontaneous precipitation
of apatite seen with supersaturated solutions of calcium and
phosphate [91]. Extending the model presented here, the protein
profiles of calcium granulations formed in the various body fluids
and tissues are predicted to largely reflect the composition of the
major calcium and apatite binding proteins available in the
surrounding milieu, a notion that had been confirmed through in
vitro experiments done on several body fluids challenged with
calcium phosphate loading [13].
The formation of mineral complexes in pathophysiological
conditions has been illustrated recently by the description of
calciprotein particles, and more specifically, by the so-called
‘‘secondary CPP,’’ which have been isolated from the ascites of a
patient suffering from calcifying peritonitis linked to kidney
disorders [30]. CPP are colloidal calcium phosphate particles
shown to transform from small, soluble, round particles (usually
smaller than 150 nm) to larger, less soluble, and more crystalline
‘‘prolate ellipsoids’’ [30,40,41,83]. Crystalline needle-like projec-
tions appeared on the round amorphous CPP within 6 hours of
incubation at 37uC, but a longer period of incubation of at least
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CPP into more crystalline secondary CPP [40,83]. The formation
of CPP in vitro requires the presence of fetuin-A for their formation
and stabilization, but the CPP found in vivo contain a low amount
of fetuin-A [30]. Instead, it appears that fetuin-A can be
substituted, at least in part, by other acidic serum proteins like
albumin, and in fact, albumin is present in high amounts in the
CPP isolated in vivo [30]. Fetuin-A present on the surface of the
CPP appears to prevent further growth and aggregation of the
particles, perhaps by reducing the diffusion of mineral ions inside
the particles [41,92]. According to Heiss, Jahnen-Dechent,
Scha ¨fer, Ketteler, and their colleagues, fetuin-A, and perhaps
other acidic proteins, should be viewed as ‘‘mineral chaperones,’’
being able to lead to the transient formation of a soluble mineral
complex for the transport and clearance of calcium and phosphate
ions under conditions of local supersaturation, a role that these
authors deem analogous to the blood transport of lipids inside
lipoprotein particles [30,68]. With time, however, this same
soluble complex undergoes phase transformation becoming
insoluble and precipitating out as crystalline apatite nuclei
[30,40,41]. Based on our own study, this same phase and solubility
transformation may also explain the dual inhibition-nucleation
concept proposed here as the basis for the formation of serum
granulations resulting from calcium phosphate loading.
Evidence that mineral complexes similar to the ones described
in this study may form in pathological conditions also comes from
the observation that treating rats with etidronate, a biopho-
sphonate known to decrease the mineralization of bones, or
vitamin D, a liposoluble vitamin known to be required for the
absorption of intestinal calcium and phosphate ions, led to the
formation of protein-mineral particles in the blood of rats [93–96].
Treatments with both molecules led to increases in the total serum
concentration of calcium and phosphate, both of which were
recovered in the form of a high molecular weight fetuin-mineral
complex [93–96]. This mineral complex, or its equivalent
prepared from calcium and phosphate added to rat serum, also
contained low amounts of matrix c-carboxyglutamic acid, secreted
phosphoprotein-24, and albumin [93–96]. Following treatment
with etidronate, an increase in the concentration of c-carbox-
yglutamic acid was detected, but the level of fetuin-A was
decreased by 50% as it was cleared from the body in association
with the mineral complexes [94]. In similar studies, decalcified
collagen fibrils of rat bones [97] or devitalized aortas [98] were
found to re-calcify when incubated in serum under physiological
concentrations of calcium and phosphate ions. The re-calcification
was attributed to one or more putative bone calcifying factor(s)
which were found to be trypsin-sensitive and estimated to have a
molecular weight of 55–150 kDa [97], now known to require
phosphorylation by alkaline phosphatase in order to become
activated [99]. Whether similar protein(s) are involved in the
nucleation of HAP associated with the serum granulations and NB
seen here is currently unclear.
That fetuin-A is indeed involved in the formation and clearance
of the mineral complexes has been elegantly established by
observations on fetuin-A knockout mice, shown to spontaneously
develop ectopic calcification of soft tissues [91]. In humans, serum
fetuin-A deficiency has been linked to calcification and cardiovas-
cular mortality [100–103]. From these studies, the lowest
concentration of fetuin-A required to prevent spontaneous
calcification of calcium phosphate in the body was estimated at
0.2 mg/ml [100], a value close to the minimal concentration of
0.1 mg/ml of fetuin-A estimated to be necessary to stabilize CPP
in the presence of other acidic serum proteins [30]. Since fetuin-A
is a negative acute phase protein, its expression spontaneously
decreases in states of inflammation [104,105] and this may have
an effect on the degree of calcification observed in pathological
conditions.
An analysis of the propensity for CPP to form in the body also
needs to take into account the amount of albumin and other
calcium and apatite binding proteins as well as the calcium
phosphate ion product present at the site of calcification [30,83].
Furthermore, in addition to albumin, several apolipoproteins and
complement components have consistently been found in
association with serum granulations. It is not clear for example
whether these proteins, especially in the case of apolipoproteins,
are part of the same protein scaffold or perhaps they may
represent distinct particles (lipoprotein particles?) that nonetheless
become calcified under the continued presence of excess calcium
phosphate. This possibility must be considered in future studies
especially since the granulations seen here are clearly heteroge-
neous from morphological and chemical standpoints. As for the
complement components 3 and 4A that have been found to bind
so avidly the serum granulations observed here, it is not clear
whether they play any immunological or pathophysiological role.
Once formed, the calcium and apatite granulations seen here
are probably siphoned for clearance, probably through the RES,
as it has also been suggested to be the case for CPP [30,40,83]. In
the context of CPP, several earlier studies have demonstrated
opsonizing properties associated with fetuin-A, which lead to the
enhancement of phagocytosis and macropinocytosis by macro-
phages of apoptotic cells, DNA, and dextran and latex particles
[106–108]. Intriguingly, the removal of calcified particles as seen
in bone remodeling and in kidney clearance is largely non-
inflammatory [83]. Thus, even the large deposits seen in fetuin-A
knockout mice show no signs of localized inflammation [83]. This
anti-inflammatory effect has been attributed tentatively to the
influence of polyanions like spermine and anti-inflammatory
cytokine proteins like transforming growth factor-b that may
become associated with the CPP [reviewed in ref. 83]. On the
other hand, the injection of apatite particles has been shown to be
fatal to Wistar rats as it induces infarction and acute thrombosis of
blood vessels in major organs like the liver and the lungs [109], a
finding thought to mimic clinical settings in which unstable
atherosclerotic lesions are also known to produce thrombosis and
even myocardial infarction. In addition, various materials that
have been nano-sized are thought to possess altered, often
increased, toxicity on living organisms compared to the same
original materials [reviewed in ref. 110], an observation which
may be related to the study which found that intravenous
injections of apatite nanoparticles produced vascular endothelial
damage in rabbits [27]. It is also possible that the main difference
between these various experimental set-ups may lie in the extent of
protein coating of these particles, presumably with a protective
and anti-inflammatory role assigned to the protein layer that is
absent in simple mineral phases—an important distinction that
warrants more detailed studies.
The potential involvement of other proteins and factors
associated with the calcium granulations seen here suggests that
these entities are much more complex than what fetuin-A alone
can possibly explain. Thus, while the elegant studies performed by
Price, Jahnen-Dechent, Heiss, Scha ¨fer, Ketteler, and their
colleagues have been centered on the role of fetuin-A as the basis
for the formation of mineralo-protein complexes, it appears that
the role of other proteins and factors must also be taken into
account to explain the biology of the serum-derived calcium
granulations observed here.
It appears that the serum calcium granulations seen here are
also closely linked to normal bone formation as well as ectopic
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mineral precursor of bone and enamel actually consists of round
amorphous nanoparticles of calcium phosphate with small sizes
ranging from 5 to 50 nm which take form inside the collagen
fibrils and that fuses in a co-linear fashion until filaments are
formed [64,111–114]. The precipitation of these round amor-
phous nanoparticles may be due to the presence of numerous
divalent cations able to freely diffuse inside the fibril and inhibit
the formation of larger and more crystalline calcium phosphate
crystals. This type of mineralization is akin to the formation of
‘‘mesocrystals’’ consisting of superstructures formed from a
repetition of individual crystals or ‘‘nanobuilding-blocks’’
[115,116]. However, the crystalline particles described in the
present study as aggregated polycrystalline material do not seem to
possess crystallographically-oriented subunits which usually give
mesocrystals a much higher degree of crystallinity [116]. Likewise,
the calcium-containing nanoparticles or granulations seen here
may represent precursors deployed for the purpose of tissue
calcification, when needed. It is conceivable that an essentially
similar association between calcium and apatite binding proteins
and mineral phases, with the resultant formation of spherical
nanoparticles, is required for biomineralization.
From a yet another perspective, the calcium and apatite complexes
seenhereappeartoresemblecalciumgranulesfoundwidelyinnature
[see ref. 29 for a most insightful review]. As such, calcium granules or
inclusion bodies appear to be the preferred form of storage or
sequestration of calcium in nature [29]. They have been studied in
more details in crustaceans [117], arthropods [118], and a variety of
invertebrates [119] where they have been found to incorporate other
metallic elements, essentially contributing to metal detoxification. In
the human blood, calcium granules have been described recently in
platelets [43] and have been found to be identical to the so-called
‘‘acidocalcisomes,’’ intracellular deposits of calcium phosphate first
found in bacteria and later studied extensively in trypanosomes [120].
Such calcium granules have been shown to play a role in the
intracellular storage of calcium and phosphate as well as in the
maintenance of the pH and osmolarity of the cell [120]. Other blood-
related clusters or complexes include proteons and the so-called
proteon-nucleating centers (PNC), representing nanoclusters of
proteins or protein fragments with metallic elements with unclear
physiological role [121].
Calcium granules have also been found in a number of other
mammalian tissues, including cartilage, atherosclerotic lesions,
kidney and cancer tissues as well as in association with Randall’s
plaque [54,55,122,123; see refs. 29 and 124 for pictures of calcium
granules obtained from a variety of organisms, including humans].
Calcium-containing granules similar to the serum granulations
and NB were also observed in association with the culture of a
human leukemia cell line [125]. When subsequently cultured in
10% FBS in the absence of this particular cell line, the mineral
particles grew slowly in culture and were shown to associate with
fetuin-A. Thin section of these same particles visualized by TEM
showed the presence of round particles with a thick wall, but,
overall, no clear biological activity was noted [125]. Based on the
widespread prevalence of these calcium granules in nature, Ryall
[29] has convincingly articulated a more plausible model viewing
them as innocuous deposits of calcium used for the various
functions of waste disposal, osmoregulation, excretion of excess
ions, ion storage and mobilization, and detoxification.
While there is marked morphological resemblance between the
serum granulations observed here and the earlier described
calcium granules [29], it should be noted that our serum
granulations also display broader pleomorphic tendencies, with
particles eventually coalescing to form shapes like spindles and
films. It is possible, and perhaps even likely, that in the continued
presence of calcium and phosphate ions the calcium granules found
throughout nature may show a similar transition to other phases
that may also include spindles and films, as mentioned earlier in the
context of Randall’s plaque observed in the kidney. Thus, in our
mind, the particular shapes assumed by calcium granulations may
simply reflect their maturation and the balance between the levels
seen for protein and other organic calcification inhibitors versus the
levels associated with calcium compounds (that is, calcium
carbonate or calcium phosphate as well as other related ions).
Accordingly, proportionally higher initial levels of protein and
organic inhibitors would be seen to favor the spherical shapes,
which appear to transition to other elongated, filamentous and
membranous shapes as a function of time as well as a result of ionic
changes in the environment. Finally, the possibility also exists that
our serum granulations may comprise of populations of distinct and
heterogeneous entities, especially since proteins with diverse and
well-known functions like apolipoproteins and complement com-
ponents are all present as part of the protein-mineral scaffold.
As for the involvement of these same granules (or NB) in human
pathologies, one area that deserves mention is kidney stone and its
linkwiththeformationofRandall’spapillaryplaque[seeref.29fora
listofrelatedreferences].ThelatterhadbeenproposedbyseveralNB
researchers as indicative of a pathogenic involvement for NB [28].
Ryall [29], and several investigators before her [126–128], have
instead taken the position that the papillary granules constituting
Randall’s plaque, seen in virtually all adult kidneys examined—
diseased or normal—are expressions of normal, rather than
anomalous or even pathological, calcium metabolism! These same
authors had earlier suggested that the same electron-dense granules
observed near the basement membranes of collecting ducts and the
interstitiumshowedgradualmigrationintoasubepitheliallocationin
the renal papillae that then form the so-called Randall’s plaque
[29,126–129]. As such, they are deemed to represent innocent
bystanders ratherthan agents of disease. Thisview stands in marked
contrast to the position expressed by Kajander and C ¸iftc ¸iog ˘lu, the
original discoverers of NB, along with other researchers, who have
proposed NB as major causative disease agents for kidney stone
formation through their coincidental presence in kidney tissues
harboring the kidney stones as well as their direct association with
Randall’s plaque [1–8,28]. According to the same authors, NB are
notonlyrenotropicbutalsoproducemorphologiesthat areidentical
to the granules seen in Randall’s plaque [1–8,28].
Regarding the involvement of NB in the development of kidney
stones as well as other disease conditions, it should be noted that our
earlier study provided a detailed analysis questioning NB both as
living organisms and as pathogenic agents of disease [13]. For
instance, our own findings indicate that all previous immunodetec-
tion studies used to ascertain the presence of NB in human tissues
were based on the erroneous assumption that monoclonal
antibodies marketed as specific for NB were actually detecting
NB-specific antigens. In fact, all monoclonal antibodies claimed to
be specific for NB that we have studied to date have shown to react
strongly to both albumin and fetuin-A, not only of the same species,
but even across species [13]. More alarmingly, our study showed
that these same antigens used to implicate NB in human tissues may
have been derived from the FBS used to culture the human tissues
under investigation, creating a bizarre and problematic scenario in
which fetal bovine antigens presumably detected by the same studies
may have inadvertently been used to assert the presence of NB in an
increasing number of human diseases [13].
In further support of this alternative position on NB that
questions their proposed involvement in the development of
kidney stones via Randall’s plaque, it should be pointed out that
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TEM images of the lamellar granules comprising Randall’s plaque
(see her Fig. 10). It should immediately be obvious that the granular
morphologies seen there are indistinguishable from those observed
for calcium granules found throughout nature as well as the serum
granulations reported here. In Ryall’s words, ‘‘It is exceedingly
puzzling that nowhere inthe large and expandingliterature devoted
to nanobacteria has there been a single reference to the long-
standing, large body of literature attesting to the existence of
calcium-containing granules in other organisms—despite the fact
thattheirphysicalandbiochemicalcharacteristicsaresosimilar.’’In
many respects, our present study vindicates the view that the same
calcium granulations found in the serum, deemed to represent
remnants of normal calcium and apatite metabolism, are not only
morphologically and chemically identical to the putative NB, but
areprobably also found in all otherbodyfluidsand tissues, as well as
throughout nature.
The NB field (including the earlier ‘‘nannobacteria’’ literature
published on geological specimens) has probably garnered more
media attention and controversy than any other field in recent
memory [see refs. 130–142 for a list of editorials written on NB in
both main science journals and popular science magazines, aside
from numerous opinions and reviews presented elsewhere]. These
controversies have stemmed not only from the extraordinary
claims made for NB as exotic and novel microorganisms or as
transmissible agents of disease, but also from a lack of biochemical,
microbiological, and structural data required for the validation of
such claims [see refs. 1–8 and the more recent review in ref. 143
advocating the claims made; see also the excellent critical review in
ref. 12 questioning the validity of these same claims]. It is this same
deficiency of information that we have attempted to address here
and elsewhere [13], by focusing on the structural and biochemical
characteristics of NB-related entities. Our studies demonstrate a
marked similarity between putative NB, serum calcium granula-
tions, and calcium granules found throughout nature, indicating
that these entities are closely related, if not identical, and that they
probably represent innocuous byproducts and remnants of
physiological reactions needed to ensure proper calcium and
phosphate homeostasis.
The calcium granulations described in this study also share
some characteristics with the so-called matrix vesicles (MV), which
represent another kind of calcium phosphate template implicated
in the formation of mineralized tissues in the body. Skeletal cells
such as osteoblasts, chondroblasts, and odontoblasts control the
deposition of minerals in the body by releasing MV which initiate
calcification in selected and restricted areas destined to be
mineralized [reviewed by Anderson et al. in ref. 144]. MV,
consisting of membrane-bound vesicles of small sizes (50–200 nm),
have thus been shown to initiate the precipitation of calcium
phosphate in bones, cartilage, and teeth [144]. The mechanism of
MV calcification apparently involves an increased concentration
of calcium and phosphate ions inside MV through the action of
calcium transporters like annexins [145] as well as enzymes like
alkaline phosphatase [146] and ATPases [147]. These latter
enzymes are known to inactivate pyrophosphate and possibly
other calcification inhibitors, thereby releasing inorganic phos-
phate from various phosphate-containing molecules [144]. In
addition, MV may contain phospholipids which bind calcium and
are thought to play a role in the nucleation of apatite [148]. Upon
exposure to high concentrations of calcium and phosphate ions, a
calcium phosphate precipitate forms inside MV and is eventually
released into the surrounding extracellular matrix following
membrane breakdown which is apparently executed by phospho-
lipases [149] as well as by proteases already present in MV [150].
Although MV are usually present only in the body’s mineralizing
compartments, MV-like structures have been detected in calcified
vasculatures and implicated as a possible nucleating agent
responsible for the deposition of apatite in these and other ectopic
calcification sites [144]. It has also been proposed that apoptotic
bodies resembling MV-like structures are released by vascular
smooth muscle cells undergoing apoptosis when, for instance, they
are confronted with high concentrations of calcium and phosphate
[151,152]. These MV-like formations were shown to harbor
fetuin-A, but the presence of this protein abrogated their ability to
induce calcification [151,152]. Presumably, by means of additional
calcium phosphate binding and saturation, these same MV-like
formations may become seeds for further apatite deposition, in line
with the dual inhibition-seeding concept for granule formation
demonstrated here. Other vesicles present in the blood have been
described under various names like membrane microparticles,
shed membrane particles, membrane vesicles, extracellular
vesicles, exosomes, among others [153]. Although these different
vesicles were implicated mainly in intercellular communication,
hemostasis, and immunity [153], it remains unclear whether such
MV-like structures or the MV described earlier are related to the
serum granulations seen in this study. Our findings of several
apolipoproteins associated with the scaffold of serum granulations
studied here as well as preliminary data pointing to the presence of
lipids in association with NB-like particles [13] would suggest a
role for lipids in the assembly of both serum granulations and NB.
Further studies will be needed to ascertain whether these are
related in anyway to the MV described earlier. However, given
that the sera used here to prepare the serum granulations or to
culture NB were obtained from healthy human volunteers or from
commercially available FBS, it appears unlikely that such material
contains MV in sufficient amounts to drive the formation of the
mineral formations observed. This is not to say that the two
pathways may not in fact coexist or even overlap in pathological
calcifications of the vasculature exposed simultaneously to blood-
related as well as extracellular influences. More experiments are
clearly needed to address these questions.
An analogy can also be drawn between the formation of the
calcium granulations presented here and the formation of polymer
gels from dissolved organic matter as described earlier [154]. In the
latter study, filtrationof ocean water through 0.22 mm filters yielded
colloid particles with diameters between 2 to 200 nm which, upon
incubation at 20uC for several hours, gradually increased in size
(200 nm to 1 mm), culminating in the formation of a network of
organic matter. The network or matrix which readily trapped
carbohydrates,proteins,andlipidsfromtheseawaterwasalsofound
to contain calcium carbonate crystals [154]. The crystallization of
calcium carbonate inside this network was attributed to a Donnan
effect which predicts that the concentration of calcium within the
matrix should be higher than that of the exterior due to the
polyanionic nature of the matrix [154]. When the pH of the water
slightly increased, precipitation of calcium carbonate occurred
withinthematrixwhiletheoutsidewaterremainedessentiallyfreeof
crystals [154]. Based on these findings, it would be interesting to
verify whether the factors found to influence the formation of
polymer gels would have a similar effecton the formationof calcium
and apatite granulations prepared from serum.
Finally, it should be noted that similar granulations have been
observed in human blood specimens and likewise described over
the past century as ‘‘inclusion bodies,’’ ‘‘filterable bodies,’’
‘‘microzymas,’’ ‘‘Granuligera,’’ ‘‘protids,’’ ‘‘somatids,’’ ‘‘blood
bacteria,’’ among others [155,156], but that have long been
relegated to questionable, if not spurious, status by the mainstream
microbiological establishment. Among the remarkable features
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calcium granulations and NB are the small, sub-micrometer sizes
granting them membrane-filterability, their proliferation like
bacteria, and their marked pleomorphism. With respect to
pleomorphism, it is intriguing that complex biological cycles
representing multiple forms ranging from round and bacilli-
shaped bacteria to filamentous fungus- and yeast-like projections
have been proposed for each one of these entities [see citations
contained in refs. 155 and 156]. Our results suggest for the first
time that the calcium and apatite granulations reported here may
provide an alternative explanation and basis for some, if not all,
aspects of this phenomenology.
Materials and Methods
Preparation of serum pellets
Human blood was collected from healthy human volunteers
using a conventional venipuncture method. The use of human
samples was approved by the Institutional Review Board of Chang
Gung Memorial Hospital (Gueishan, Taiwan, Republic of China)
and supported by written informed consents. Whole blood was
collected into Vacutainer tubes without anticoagulant (Becton,
Dickinson & Company, Sparks, MD, USA) and centrifuged at
1,5006g for 15 min at room temperature. The supernatant
corresponding to HS was saved into another tube. FBS (Biological
Industries, Kibbutz Beit Haemek, Israel) and HS were successively
filtered through 0.2 mm and 0.1 mm membranes prior to use.
Serum pellets were prepared by adding sterile solutions of either
0.25 M CaCl2, pH 7.4, or 0.25 M Na2HPO4 (adjusted to pH 7.4
with 0.25 M NaH2PO4), or a combination of both, into filtered
FBS or HS (2.5 ml) at final concentrations ranging from 12 mM to
48 mM for CaCl2, 6 mM to 24 mM for Na2HPO4, or 1 mM to
2 mM of each when both CaCl2 and Na2HPO4 were added. The
serum pellets shown in Figs. 1, 2 and 5–11 were prepared either
from untreated serum (labeled in the figures as FBS-1/HS-1) or by
adding either 48 mM CaCl2 (labeled as FBS-2/HS-2), 24 mM
Na2HPO4 (labeled as FBS-3/HS-3), or 2 mM of both CaCl2 and
Na2HPO4 (labeled as FBS-4/HS-4) to the serum. Ion solutions
were added drop-wise with vigorous agitation to avoid precipita-
tion. Treated or control sera were incubated at 37uC for 2 hours
(used for Figs. 3 and 4) or overnight at room temperature (used for
Figs. 1, 2, and 5–11) with gentle, end-over-end shaking. Following
incubation, the serum solutions were centrifuged at 16,0006g for
1 hour and the pellets were washed successively with 0.2 mm
membrane-filtered Dulbecco’s Modified Eagle’s Medium
(DMEM; Gibco, Carlsbad, CA, USA) or HEPES buffer (20 mM
HEPES, 1 mM CaCl2, 2 mM Na2HPO4, 0.02% sodium azide,
and 0.15 M NaCl, pH 7.4) using the same centrifugation steps.
Alternatively, the untreated serum pellets were prepared by
incubating filtered FBS or HS (38 ml) with gentle agitation
overnight at room temperature, followed by centrifugation at
140,0006g at 4uC for 2 hours using a L8-80M ultracentrifuge
(Beckman Coulter, Fullerton, CA, USA). The pellets were then
washed twice with either filtered DMEM, HEPES buffer, or
double distilled water using the same centrifugation steps.
For Fig. 1, the pellets were resuspended in 100 ml of HEPES
buffer. Small aliquots of these suspensions (2 mlt o1 5ml) were
diluted into serum-free DMEM, DMEM without calcium (Gibco),
or DMEM without phosphate (Gibco) in a final volume of 1 ml
using 24 well plates. 1 ml of serum-free DMEM receiving no
inoculation was also incubated in the same conditions as a negative
control. The plates were incubated at 37uC in cell culture
conditions. Visual inspection, photography, and optical density
monitoring at A650 were done as before [13]. Serum pellets
described as FBS-29 and FBS-20 in Fig. 7 were prepared by adding
48 mM CaCl2 to FBS, followed by either a short incubation of
1 hour (FBS-29) or overnight (FBS-20) at room temperature, and
were processed as described above.
Culture and preparation of NB specimens
Putative NB were obtained from FBS or HS as described earlier
[ 2 , 1 5 7 ] .B r i e f l y ,F B So rH Sw e r ef i l t e r e dt h r o u g ha0 . 2 mm
membrane, diluted 1:10 to 1:300 in DMEM, followed by incubation
at 37uC in cell culture conditions for several weeks. The Nanobacterium
sp. strains designated as DSM 5820 and DSM 5821, initially isolated
from commercially available FBS [36], was obtained from the
German Collection of Microorganisms and Cell Cultures (DSMZ;
Braunschweig, Germany). This strain, along with two others used in
our previous study [13], had earlier been deposited by Dr. E. Olavi
Kajander (Nanobac Oy, Neulaniementie, Finland) into the DSMZ in
association with a patent issued in1992 describing the isolation of NB
(USA patent #5,135,851). The strain of NB designated as ‘‘nanons’’
[15] was provided by Dr. Didier Raoult(Unite ´ des Rickettsies, Centre
National de la Recherche Scientifique UMR 6020, Faculte ´d e
Me ´decine, Marseille, France). This strain was initially isolated from
FBS and named ‘‘Nanobacterium sp. strain Seralab 901045’’ [15,157].
The different NB strains were scraped from a T-75 cm
2 flask
(Corning, Inc., Corning, NY, USA)showing abundant culture and an
aliquot of 2 ml was centrifugated at 16,0006g at room temperature
for 15 min. The pellet was washed twice with HEPES buffer or
double distilled water using the same centrifugation steps. NB were
then resuspended in double distilled water and used as such for the
different microscopy, spectroscopy, and proteomic analyses.
Preparation of seeding-pellets obtained from serum
treated with trypsin or chymotrypsin
Serum pellets used for the experiment described on Fig. 12 were
prepared by adding aliquots of a 0.2 mmfiltratedsolutionof5%(w/v)
porcine pancreas trypsin (Sigma, St-Louis, MO, USA) or bovine
pancreas chymotrypsin (Sigma) into either filtrated FBS or HS (1 ml)
to a final concentration of 0.5% (v/v). The solutions were then
incubated with gentle end-over-end agitation at 37uC for 2 hours or
overnight. After incubation, the solutions were centrifuged at
16,0006g at room temperature for 1 hour. The pellets were then
washed twice with HEPES buffer and were resuspended in 100 mlo f
the same buffer. Small aliquots (10 ml)of the resuspended pellets were
inoculated into DMEM and incubated in cell culture conditions. FBS
and HS that received no treatmentwith trypsin or chymotrypsin were
processed exactly the same way as controls.
Optical dark field microscopy
Washed serum pellets and NB samples were resuspended in
double distilled water and aliquots were deposited on glass slides.
The samples were visualized without fixation or staining with a
BX-51 optical microscope (Olympus, Tokyo, Japan) equipped
with a dark field condenser (Cerbe Distribution, Inc., Sherbrooke,
Que ´bec, Canada) and a 1006 oil immersion objective with iris
(UPlanFLN; Olympus). The specimens were visualized at a
magnification of 1,0006 and the images were acquired with a
Spot Flex color, charge-coupled device (CCD) camera (Diagnostic
Instruments, Inc., Sterling Heights, MI, USA). Commercially
available HAP (buffered aqueous suspension, 25% w/v; Sigma)
was used here as well as throughout this study as a control.
Electron microscopy
For scanning electron microscopy (SEM), washed serum pellets
and NB specimens were resuspended in double distilled water and
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under a laminar flow hood, the specimens were coated with gold for
90 seconds and observed with a SEM S-5000 field-emission
scanning electron microscope (Hitachi Science Systems, Tokyo,
Japan). For transmission electron microscopy (TEM), washedserum
pellets and NB samples were deposited on formvar carbon-coated
grids without staining; the excess liquid was removed with an
absorbent paper, and the grids were then dried overnight. For thin
sections, the same specimens were washed twice in double distilled
water and dehydrated with two washes of 100% ethanol. The
samples were then embedded in Epon 812 resin (Electron
Microscopy Sciences, Fort Washington, PA, USA) and incubated
at 72uC for 2 days to allow resin polymerization. Thin sections were
cut using a Leica Ultracut UCT microtome (Leica Microsystems
GmbH, Wetzlar, Germany) and were transferred on formvar
carbon-coated grids. Specimens prepared for TEM were observed
without staining with a JEOL JEM-1230 transmission electron
microscope (JEOL, Tokyo, Japan) operated at 120 keV.
X-ray and electron diffraction analyses
Washed serum pellets and NB specimens resuspended in double
distilled water were deposited on glass slides and dried overnight.
Powder X-ray diffraction spectroscopy (XRD) was performed
using a Bruker AXS D5005 X-ray diffractometer (Bruker AXS,
Madison, WI, USA) equipped with a sealed 2.2 kW copper X-ray
source, a diffracted beam monochromator, and a scintillation
counter detector. Experimental diffraction spectra were compared
with the database of the Joint Committee on Powder Diffraction
and Standards (JPCDS) in order to identify the chemical formula
of each crystalline compound. Electron diffraction patterns were
acquired with a JEOL JEM-1230 transmission electron micro-
scope (JEOL) operated at 120 keV.
Energy-dispersive X-ray spectroscopy
Aliquots of washed serum pellets and NB specimens resus-
pended in water were deposited on formvar carbon-coated grids
and dried overnight. Energy-dispersive X-ray spectroscopy (EDX)
was performed using a SEM S-3000N scanning electron
microscope (Hitachi Science Systems) equipped with an EMAX
Energy EX-400 EDX device (Horiba, Tokyo, Japan) as described
before [13]. Commercially available CaCO3 (A.C.S. grade
reagent, purity 99.6%, Mallinckrodt Baker, Inc., Phillipsburg,
NJ, USA) and calcium phosphate tribasic (Kanto Chemical Co.,
Tokyo, Japan), also labeled as Ca3(PO4)2 in the figures, were used
for comparison with the experimental specimens.
Fourier-transformed infrared spectroscopy
Washed and dried serum pellets and NB specimens were mixed
1:100 (w/w) with KBr powder and compressed with a hand press
to form a thin pellicle. FTIR spectroscopy was performed using a
Nicolet 5700 FTIR spectrometer (Thermo Fisher Scientific,
Waltham, MA, USA) equipped with a deuterated triglycine sulfate
(DTGS) detector. Each spectrum was obtained at a resolution of
4c m
21 and represented an average of 32 consecutive scans.
Micro-Raman spectroscopy
Washed serum pellets and NB samples were resuspended indouble
distilled water and deposited on glass slides.The specimens were then
dried overnight at room temperature under a laminar flow hood.
Micro-Raman spectroscopy was performed using the inVia Raman
confocal microscope (Renishaw, Stonehouse, UK) equipped with a
CCD detector. A laser beam of 633 nm operated at 17 mW was
focused on the specimens and provided the excitation source.
Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE)
2 mlaliquotsofeach100 mlpelletsuspensiondescribedearlierwere
successively mixed with 14 mlo f5 0 m ME D T Aa n d4 mlo f
concentrated ‘‘loading buffer’’ (0.313 M Tris-HCl pH 6.8, 10%
SDS, 0.05% bromophenol blue, 50% glycerol, 12.5% b-mercapto-
ethanol).Theproteinsampleswereheatedat95uCfor5 minpriortogel
electrophoresisusingamini-gelsystem(Hoefer,Holliston,MA,USA).
ThegelswerethenstainedwithCoomassieblueasdescribed[13].
Matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF) mass spectrometry
Protein bands from gels were excised, reduced and alkylated, in-
gel digested with trypsin, and further processed for mass
spectrometry (MS) [13]. MS and tandem MS/MS spectra were
obtained with an Ultraflex TOF-TOF mass spectrometer (Bruker
Daltonics, Bremen, Germany). Selected peaks were fragmented by
the LIFT method to confirm the identity of the highest score
protein by MS/MS analysis.
In addition, serum pellet and NB samples were submitted to in-
solution trypsin digestion as described earlier [13]. Serum pellets
and NB washed twice in DMEM and once in distilled water were
successively reduced, alkylated, and digested with trypsin directly
in solution [13]. Peptides were dried in a vacuum centrifuge at
room temperature for 10 min. The dried peptides were then
resuspended in 0.1% formic acid (Sigma), loaded onto a reversed-
phase liquid chromatography trap column (Zorbax 300SB-C18,
Agilent Technologies, Wilmington, DE, USA), and separated
using a 10 cm analytical C18 column (New Objective, Woburn,
MA, USA). Elution was performed with a succession of different
solutions containing an increasing concentration of formic acid
(starting with 0.1% formic acid diluted in 99.9% acetonitrile). The
liquid chromatography column was placed in line with a 2-D
linear ion trap mass spectrometer (LTQ-Orbitrap; Thermo Fisher)
operated using the Xcalibur 2.0 software (Thermo Fisher).
Mass fingerprints were searched against the Swiss-Prot database
using the MASCOT search engine (Matrix Sciences, London, UK)
as described before [13]. The criteria for positive protein
identification included a score above the MASCOT threshold of
chance expectation value (p,0.05), a molecular weight correspond-
ing to the band obtained on the SDS-PAGE, and a confirmation of
the highest score protein by MS/MS analysis of two selected peaks.
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